Fabrinet sets December 10 annual shareholder vote
Fiscal 2026 revenue rose 35.7% and net income rose 42.3% compared with fiscal 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Fabrinet asks shareholders at its December 10, 2026 annual meeting to elect Seamus Grady and Thomas F. Kelly as Class II directors, ratify PricewaterhouseCoopers ABAS Ltd. as independent auditor for the fiscal year ending June 25, 2027, and approve named executive officer compensation on a non-binding, advisory basis. The Board recommends a vote “FOR” each proposal. The meeting is virtual and shareholders of record as of October 13, 2026 are entitled to vote. The director nominees receiving the highest number of affirmative votes will be elected; the other two proposals require a majority of votes cast.
Fabrinet reported fiscal 2026 revenue of $4,641.1 million, up 35.7% from fiscal 2025, and net income of $473.0 million, up 42.3%. Net income per diluted share was $13.05, up 42.3%; Fabrinet described this as its sixth successive fiscal year of record revenue, net income and net income per diluted share. It repurchased 13,766 ordinary shares for an aggregate purchase price of $5.2 million during fiscal 2026, which it said offset dilution from equity-plan issuances. As of October 13, 2026, 35,833,867 ordinary shares were outstanding and entitled to vote; 3,964,001 treasury shares were not entitled to vote.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Positive
- Moderate pointFiscal 2026 revenue rose 35.7% to $4,641.1 million.
- Moderate pointFiscal 2026 net income rose 42.3% to $473.0 million.
Negative
- None.
Key Figures
Key Terms
say-on-pay financial
broker “non-votes” financial
restricted share units financial
non-GAAP net income per diluted share financial
Compensation Summary
- Election of two Class II directors
- Ratification of the appointment of PricewaterhouseCoopers ABAS Ltd. as independent auditor for the fiscal year ending June 25, 2027
- Advisory vote to approve named executive officer compensation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
When is FN’s 2026 annual meeting?
How many FN shares are entitled to vote at the 2026 annual meeting?
What were Fabrinet’s fiscal 2026 revenue and net income?
What is the deadline for proposals in FN’s 2027 proxy statement?
AI-generated analysis. How Rhea-AI works. Not financial advice.
TABLE OF CONTENTS
☐ | Preliminary Proxy Statement |
☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
☒ | Definitive Proxy Statement |
☐ | Definitive Additional Materials |
☐ | Soliciting Material Pursuant to Section 240.14a-12 |
(Name of Registrant as Specified in its Charter) |
(Name of Person(s) Filing Proxy Statement, if other than the Registrant) |
☒ | No fee required | |||||
☐ | Fee paid previously with preliminary materials | |||||
☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 | |||||
TABLE OF CONTENTS

TABLE OF CONTENTS

1. | Elect two Class II directors named in the proxy statement and recommended by Fabrinet’s board of directors to serve for a term of three years and until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal; |
2. | Ratify the appointment of PricewaterhouseCoopers ABAS Ltd. as Fabrinet’s independent registered public accounting firm for Fabrinet’s fiscal year ending June 25, 2027; |
3. | Hold a non-binding, advisory vote to approve the compensation of Fabrinet’s named executive officers, as disclosed in the proxy statement; and |
4. | Conduct any other business as may properly come before the meeting or any adjournment or postponement thereof. |
TABLE OF CONTENTS
By order of the Board of Directors, | |||
/s/ Seamus Grady | |||
Seamus Grady Chief Executive Officer and Chairman of the Board of Directors | |||
Grand Cayman, Cayman Islands October 20, 2026 | |||
Important Notice Regarding the Availability of Proxy Materials for the Annual General Meeting of Shareholders to Be Held on Thursday, December 10, 2026 The proxy statement and our Fiscal 2026 Annual Report to Shareholders are available at www.proxyvote.com. | ||
TABLE OF CONTENTS
Page | |||
2026 PROXY STATEMENT SUMMARY | 1 | ||
2026 Annual General Meeting | 1 | ||
Matters to Be Voted on at the Annual Meeting | 1 | ||
Business and Financial Highlights | 2 | ||
Governance Highlights | 3 | ||
Executive Compensation Program Highlights | 4 | ||
QUESTIONS AND ANSWERS ABOUT THE ANNUAL MEETING AND PROCEDURAL MATTERS | 7 | ||
How can I attend the Annual Meeting? | 7 | ||
Can shareholders ask questions during the Annual Meeting? | 7 | ||
Who is entitled to vote at the Annual Meeting? | 7 | ||
Why did I receive a one-page notice in the mail regarding the Internet availability of proxy materials instead of a full set of proxy materials? | 7 | ||
What proposals will be voted on at the Annual Meeting? | 8 | ||
How does the Board of Directors recommend that I vote? | 8 | ||
What is the voting requirement to approve each of the proposals and how are votes counted? | 8 | ||
How many shares must be present or represented to conduct business at the Annual Meeting? | 8 | ||
How can I vote my shares during the Annual Meeting? | 9 | ||
How can I vote my shares without attending the Annual Meeting? | 9 | ||
What is the difference between holding shares as a shareholder of record and as a beneficial owner? | 9 | ||
What happens if additional matters are presented at the Annual Meeting? | 10 | ||
Can I change my vote? | 10 | ||
What happens if I decide to attend the Annual Meeting but I have already voted or submitted a proxy card covering my shares? | 10 | ||
What should I do if I receive more than one set of voting materials? | 10 | ||
Is my vote confidential? | 10 | ||
Where can I find the voting results of the Annual Meeting? | 10 | ||
Who will bear the cost of soliciting votes for the Annual Meeting? | 11 | ||
What is the deadline to propose actions for consideration at next year’s annual meeting of shareholders or to nominate individuals to serve as directors? | 11 | ||
How may I obtain a separate set of proxy materials or the Fiscal 2026 Annual Report? | 12 | ||
Whom do I contact if I have questions? | 12 |
Page | |||
FISCAL YEAR END | 13 | ||
PROPOSAL ONE: ELECTION OF DIRECTORS | 14 | ||
General | 14 | ||
Nominees for Director | 14 | ||
Recommendation of the Board of Directors | 14 | ||
Biographical Information | 15 | ||
DIRECTOR COMPENSATION | 22 | ||
Annual Non-Employee Director Compensation Elements | 22 | ||
Fiscal 2026 Director Compensation Table | 23 | ||
Director Share Ownership Guidelines | 23 | ||
CORPORATE GOVERNANCE MATTERS | 24 | ||
Corporate Governance Guidelines | 24 | ||
Code of Business Conduct | 24 | ||
Majority Voting Director Resignation Policy in Uncontested Elections | 24 | ||
Board Leadership Structure | 24 | ||
Risk Oversight | 25 | ||
Information Security Risk Oversight and Management | 25 | ||
Director Independence | 26 | ||
Board Meetings and Committees | 26 | ||
Attendance at Annual Meetings of Shareholders by the Board of Directors | 27 | ||
Contacting the Board of Directors | 27 | ||
Share Ownership Guidelines | 28 | ||
Insider Trading Policy | 28 | ||
Prohibited Transactions in Our Securities | 29 | ||
Compensation Committee Interlocks and Insider Participation | 29 | ||
Director Re-Nomination Process | 29 | ||
Process for Recommending Candidates for Election to the Board of Directors | 30 | ||
ENVIRONMENTAL, SOCIAL AND GOVERNANCE (ESG) PRACTICES AND POLICIES | 31 | ||
Overview | 31 | ||
Environmental | 31 | ||
Social | 31 | ||
Governance | 32 |
TABLE OF CONTENTS
Page | |||
PROPOSAL TWO: RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM | 34 | ||
General | 34 | ||
Recommendation of the Board of Directors | 34 | ||
Accounting Fees | 34 | ||
Auditor Independence | 34 | ||
Pre-Approval of Audit and Non-Audit Services | 34 | ||
PROPOSAL THREE: ADVISORY VOTE TO APPROVE COMPENSATION OF NAMED EXECUTIVE OFFICERS | 35 | ||
General | 35 | ||
Recommendation of the Board of Directors | 35 | ||
AUDIT COMMITTEE REPORT | 36 | ||
EXECUTIVE OFFICERS | 37 | ||
EXECUTIVE COMPENSATION | 38 | ||
Compensation Discussion and Analysis | 38 | ||
Compensation and Risk Assessment | 49 | ||
Compensation Committee Report | 49 | ||
Summary Compensation Table | 50 | ||
Grants of Plan-Based Awards in Fiscal 2026 | 52 | ||
Outstanding Equity Awards at Fiscal 2026 Year-End | 53 | ||
Option Exercises and Shares Vested in Fiscal 2026 | 54 | ||
Potential Payments Upon Termination or Change of Control | 55 | ||
ADDITIONAL COMPENSATION MATTERS | 62 | ||
CEO Pay Ratio | 62 | ||
Pay Versus Performance | 62 | ||
Policies and Practices Related to the Grant of Certain Equity Awards | 66 |
Page | |||
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS | 67 | ||
Related Party Transactions | 67 | ||
Policy for Approval of Related Party Transactions | 67 | ||
SECURITY OWNERSHIP BY PRINCIPAL SHAREHOLDERS AND MANAGEMENT | 68 | ||
EQUITY COMPENSATION PLAN INFORMATION | 69 | ||
NO DELINQUENT SECTION 16(a) REPORTS | 69 | ||
OTHER MATTERS | 69 | ||
APPENDIX A – GAAP TO NON-GAAP RECONCILIATION | A-1 |
TABLE OF CONTENTS
Date: | Thursday, December 10, 2026 | ||||
Time: | 9:00 a.m. Pacific Standard Time | ||||
Location: | Online via the Internet at www.virtualshareholdermeeting.com/FN2026 | ||||
Record Date: | October 13, 2026 | ||||
Voting: | Shareholders as of the record date are entitled to vote. Shareholders may cast one vote for each ordinary share held by them as of the record date on all matters properly presented at the Annual Meeting. At the close of business on the record date, there were 35,833,867 ordinary shares outstanding and entitled to vote at the Annual Meeting, as well as 3,964,001 ordinary shares outstanding and held as treasury shares (which are not entitled to vote). | ||||
Admission to Meeting: | You are entitled to attend the Annual Meeting online, vote and submit questions during the meeting by visiting www.virtualshareholdermeeting.com/FN2026 and entering the 16-digit control number included on your Notice of Internet Availability of Proxy Materials, voting instruction form or proxy card (if you requested printed materials). You will only be entitled to vote and submit questions at the Annual Meeting if you are a shareholder as of the record date. | ||||
Matter | Board Recommendation | Page Reference for More Information | |||||||||
Proposal 1: | Election of two Class II directors | “FOR” each nominee | Page 14 | ||||||||
Proposal 2: | Ratification of the appointment of PricewaterhouseCoopers ABAS Ltd. as Fabrinet’s independent auditor for the fiscal year ending June 25, 2027 | “FOR” | Page 34 | ||||||||
Proposal 3: | Advisory vote to approve named executive officer compensation | “FOR” | Page 35 | ||||||||
Name | Tenure (Years) | Experience and Qualifications | Board Committees | ||||||||
Seamus Grady | 9 | CEO experience and deep industry knowledge | None | ||||||||
Thomas F. Kelly | 16 | Extensive managerial and operational experience; audit, financial reporting and cybersecurity expertise | Audit (Chair), Compensation | ||||||||
![]() | 2026 PROXY STATEMENT | 1 | ||
TABLE OF CONTENTS
Fiscal 2026(1) | Fiscal 2025 | Change | |||||||||
Revenue | $4,641.1 million | $3,419.3 million | 35.7% | ||||||||
GAAP gross margin | 12.0% | 12.1% | (10 basis points) | ||||||||
Non-GAAP gross margin(2) | 12.2% | 12.4% | (20 basis points) | ||||||||
Operating margin | 10.0% | 9.5% | 50 basis points | ||||||||
Non-GAAP operating margin(2) | 10.8% | 10.5% | 30 basis points | ||||||||
Net income | $473.0 million | $332.5 million | 42.3% | ||||||||
Non-GAAP net income(2) | $510.9 million | $368.8 million | 38.5% | ||||||||
Net income per diluted share | $13.05 | $9.17 | 42.3% | ||||||||
Non-GAAP net income per diluted share(2) | $14.09 | $10.17 | 38.5% | ||||||||
Closing share price (on business day following announcement of fiscal year-end results) | $454.55 | $285.23 | 59.4% |
(1) | Please see the section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for our fiscal year ended June 26, 2026 (filed with the Securities and Exchange Commission on August 18, 2026), for a more detailed discussion of our fiscal 2026 financial results. |
(2) | Please refer to Appendix A for a reconciliation of this non-GAAP financial measure to the most directly comparable financial measure calculated in accordance with generally accepted accounting principles in the United States (“GAAP”). |
2 | ![]() | 2026 PROXY STATEMENT | ||||
TABLE OF CONTENTS
| Board independence (5 out of 6 directors are independent) |
| Independent directors regularly meet in executive sessions without management present |
| Incumbent directors attended 100% of Board and Committee meetings held in fiscal 2026 |
| Diversity of Board skills and experience |
| Annual Board and Committee evaluations |
| Strong corporate governance guidelines and policies |
| Majority voting director resignation policy for uncontested elections |
| Share ownership guidelines for executive officers and directors |
| Succession planning process |
| Shareholder outreach program |
| Board risk oversight and assessment |
| Board refreshment (2 out of 6 directors have a tenure of less than 5 years) |

Forbes I.J. Alexander | Dr. Homa Bahrami | Caroline Dowling | Seamus Grady | Thomas F. Kelly | Dr. Frank H. Levinson | ||||||||||||||||||
Executive Leadership | • | • | • | • | • | • | |||||||||||||||||
Industry | • | • | • | • | |||||||||||||||||||
Operational Manufacturing | • | • | • | • | |||||||||||||||||||
Finance | • | • | • | • | • | • | |||||||||||||||||
Global Leadership | • | • | • | • | • | • | |||||||||||||||||
Business Development & Strategy | • | • | • | • | • | • | |||||||||||||||||
Information Security | • | ||||||||||||||||||||||
Other Public Co. Board Experience | • | • | • | • | • | ||||||||||||||||||
![]() | 2026 PROXY STATEMENT | 3 | ||
TABLE OF CONTENTS
✔ What We Do | ||
| Pay-for-performance, with significant portion of compensation at risk |
| Caps on performance-based incentive compensation |
| Multi-year performance periods |
| Clawback policy on cash and equity incentive compensation |
| Share ownership guidelines for executive officers and directors |
| 100% independent directors on the Compensation Committee |
| Independent compensation consultant engaged by the Compensation Committee |
| Annual review and approval of our compensation strategy |
| Engagement with shareholders |
| Annual shareholder advisory vote on executive compensation |
× What We Don’t Do | ||
| No targeting specific percentiles |
| No guaranteed bonus |
| No changing of multi-year targets after they are set |
| No repricing or buyouts of equity awards |
| No share “recycling” |
| No short sales, hedging, or pledging of our ordinary shares |
| No transactions involving derivatives of our ordinary shares |
| No paying dividends or dividend equivalents on unvested equity awards |

4 | ![]() | 2026 PROXY STATEMENT | ||||
TABLE OF CONTENTS


![]() | 2026 PROXY STATEMENT | 5 | ||
TABLE OF CONTENTS

6 | ![]() | 2026 PROXY STATEMENT | ||||
TABLE OF CONTENTS
Q: | How can I attend the Annual Meeting? |
A: | You are invited to attend the Annual Meeting if you were a shareholder of record or a beneficial owner as of October 13, 2026 (the “Record Date”). Shareholders may participate in the Annual Meeting at www.virtualshareholdermeeting.com/FN2026. Guests will not be able to vote shares or ask questions during the meeting. |
Q: | Can shareholders ask questions during the Annual Meeting? |
A: | Yes. Shareholders may submit questions online in advance of, or during, the Annual Meeting. |
Q: | Who is entitled to vote at the Annual Meeting? |
A: | You may vote your Fabrinet ordinary shares if our records show that you owned your shares at the close of business on the Record Date. At the close of business on the Record Date, there were 35,833,867 ordinary shares outstanding and entitled to vote at the Annual Meeting, as well as 3,964,001 ordinary shares outstanding and held as treasury shares (which are not entitled to vote). You may cast one vote for each ordinary share held by you as of the Record Date on all matters presented. |
Q: | Why did I receive a one-page notice in the mail regarding the Internet availability of proxy materials instead of a full set of proxy materials? |
A: | In accordance with rules adopted by the Securities and Exchange Commission (the “SEC”), we have elected to provide access to our proxy materials over the Internet. Accordingly, we began sending a Notice of Internet Availability of Proxy Materials (the “Notice”) |
![]() | 2026 PROXY STATEMENT | 7 | ||
TABLE OF CONTENTS
Q: | What proposals will be voted on at the Annual Meeting? |
A: | The proposals scheduled to be voted on are: |
One: | Election of two Class II directors listed in this proxy statement and recommended by the Board to serve for a term of three years and until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal. |
Two: | Ratification of the appointment of PricewaterhouseCoopers ABAS Ltd. as our independent registered public accounting firm for our fiscal year ending June 25, 2027. |
Three: | A non-binding, advisory vote to approve the compensation of our named executive officers, as disclosed herein. |
Q: | How does the Board of Directors recommend that I vote? |
A: | The Board recommends that you vote your shares: |
• | “FOR” each of the nominees listed in this proxy statement and recommended by the Board for election as Class II directors (Proposal One). |
• | “FOR” the ratification of the appointment of PricewaterhouseCoopers ABAS Ltd. as our independent registered public accounting firm for our fiscal year ending June 25, 2027 (Proposal Two). |
• | “FOR” the approval of the compensation of our named executive officers (Proposal Three). |
Q: | What is the voting requirement to approve each of the proposals and how are votes counted? |
A: | Proposal One. A plurality of the votes cast is required for the election of directors. You may vote “FOR” or “WITHHOLD” on each nominee for election as |
Q: | How many shares must be present or represented to conduct business at the Annual Meeting? |
A: | The presence of the holders of at least one-third of the total shares entitled to vote at the Annual Meeting is necessary to constitute a quorum at the Annual Meeting. Such shareholders are counted as present at the meeting if (1) they are present virtually at the Annual Meeting or (2) have properly submitted a proxy. Abstentions and broker “non-votes” are counted as present and entitled to vote and are, therefore, included for the purposes of determining whether a quorum is present at the Annual Meeting. A broker “non-vote” occurs when a nominee holding shares for a beneficial owner has not received voting instructions from the beneficial owner, and the broker does not have, or declines to exercise, discretionary authority to vote those shares. |
8 | ![]() | 2026 PROXY STATEMENT | ||||
TABLE OF CONTENTS
Q: | How can I vote my shares during the Annual Meeting? |
A: | Shareholders of record may vote their shares electronically during the Annual Meeting by logging into www.virtualshareholdermeeting.com/FN2026. |
Q: | How can I vote my shares without attending the Annual Meeting? |
A: | Whether you hold shares directly as the shareholder of record or beneficially in street name, you may direct how your shares are voted without attending the Annual Meeting. If you are a shareholder of record, you may vote by submitting a proxy; please refer to the voting instructions in the Notice or below. |
Q: | What is the difference between holding shares as a shareholder of record and as a beneficial owner? |
A: | Shareholder of Record. If your shares are registered directly in your name with our transfer agent, Computershare Trust Company, you are considered the “shareholder of record” with respect to those shares, and we have sent the Notice directly to you. As a shareholder of record, you have the right to grant your voting proxy directly to us or to a third party, or to vote virtually during the Annual Meeting. |
![]() | 2026 PROXY STATEMENT | 9 | ||
TABLE OF CONTENTS
• | Your broker will have the authority to exercise discretion to vote your shares with respect to the ratification of the appointment of PricewaterhouseCoopers ABAS Ltd. as our independent registered public accounting firm for our fiscal year ending June 25, 2027, because the rules of The New York Stock Exchange (“NYSE”) treat that matter as routine. |
• | Your broker will not have the authority to exercise discretion to vote your shares with respect to the election of directors and the advisory vote to approve the compensation of our named executive officers because NYSE rules treat those matters as non-routine. |
Q: | What happens if additional matters are presented at the Annual Meeting? |
A: | If any other matters are properly presented for consideration at the Annual Meeting, including, among other things, consideration of a motion to adjourn the Annual Meeting to another time or place (including, without limitation, for the purpose of soliciting additional proxies), the persons named as proxy holders will have discretion to vote on those matters in accordance with their best judgment. We do not currently anticipate that any other matters will be raised at the Annual Meeting. |
Q: | Can I change my vote? |
A: | Subject to any rules your broker, bank or nominee may have, you may change your vote at any time before the electronic polls close at the Annual Meeting. |
Q: | What happens if I decide to attend the Annual Meeting but I have already voted or submitted a proxy card covering my shares? |
A: | Subject to any rules your broker, bank or nominee may have, you may attend the Annual Meeting and vote during the meeting even if you have already voted or submitted a proxy card. Any previous votes that were submitted by you will be superseded by the vote you cast at the Annual Meeting. Please be aware that attendance at the Annual Meeting will not, by itself, revoke a proxy. |
Q: | What should I do if I receive more than one set of voting materials? |
A: | If you received more than one Notice, voting instruction card or set of proxy materials, your shares are registered in more than one name or brokerage account. Please follow the instructions on each Notice or voting instruction card that you receive, to ensure that all of your shares are voted. |
Q: | Is my vote confidential? |
A: | Proxy instructions, ballots and voting tabulations that identify individual shareholders are handled in a manner that protects your voting privacy. Your vote will not be disclosed either within Fabrinet or to third parties, except: (1) as necessary to meet applicable legal requirements, (2) to allow for the tabulation of votes and certification of the vote, and (3) to facilitate a successful proxy solicitation. Occasionally, shareholders provide written comments on their proxy cards, which may be forwarded to Fabrinet’s management. |
Q: | Where can I find the voting results of the Annual Meeting? |
A: | We will announce preliminary voting results at the Annual Meeting. We will also disclose voting results on a Form 8-K filed with the SEC within four business days after the Annual Meeting, which will also be available in the “Investors—Financials & Filings—SEC Filings” section of our website at www.fabrinet.com. |
10 | ![]() | 2026 PROXY STATEMENT | ||||
TABLE OF CONTENTS
Q: | Who will bear the cost of soliciting votes for the Annual Meeting? |
A: | We will pay the entire cost of preparing, assembling, printing, mailing and distributing these proxy materials and soliciting votes. We may reimburse brokerage firms, custodians, nominees, fiduciaries and other persons representing beneficial owners for their reasonable expenses in forwarding solicitation material to such beneficial owners. We have engaged Kingsdale Advisors as our shareholder advisor and proxy solicitation agent and will pay fees of approximately $20,500, plus certain out-of-pocket expenses, to Kingsdale Advisors to assist us with the solicitation of proxies. Our directors, officers and employees also may solicit proxies in person or by other means of communication. Such directors, officers and employees will not be additionally compensated, but may be reimbursed for reasonable out-of-pocket expenses in connection with such solicitation. |
Q: | What is the deadline to propose actions for consideration at next year’s annual meeting of shareholders or to nominate individuals to serve as directors? |
A: | Shareholders may submit proposals, including recommendations of director candidates, for consideration at future shareholder meetings. |
![]() | 2026 PROXY STATEMENT | 11 | ||
TABLE OF CONTENTS
Q: | How may I obtain a separate set of proxy materials or the Fiscal 2026 Annual Report? |
A: | If you share an address with another shareholder, each shareholder may not receive a separate copy of our proxy materials and Fiscal 2026 Annual Report. Upon written request we will promptly send a separate copy of our proxy materials and Fiscal 2026 Annual Report, without charge, to any shareholder at a shared address where a single copy of the documents was |
Q: | Whom do I contact if I have questions? |
A: | If you have any questions or need assistance completing your proxy or voting instruction form, please contact Kingsdale Advisors by telephone at (866) 228-3049 (toll-free within North America) or (646) 741-3814 (call collect outside of North America), or by email at contactus@kingsdaleadvisors.com. |
12 | ![]() | 2026 PROXY STATEMENT | ||||
TABLE OF CONTENTS
![]() | 2026 PROXY STATEMENT | 13 | ||
TABLE OF CONTENTS
Class I Directors (Terms Expire in 2028) | Class II Directors (Terms Expire at Annual Meeting) | Class III Directors (Terms Expire in 2027) | ||||||
Dr. Homa Bahrami | Seamus Grady(1) | Forbes I.J. Alexander | ||||||
Caroline Dowling | Thomas F. Kelly(1) | Dr. Frank H. Levinson | ||||||
(1) | Nominee for election at the Annual Meeting for a three-year term expiring in 2029. |
14 | ![]() | 2026 PROXY STATEMENT | ||||
TABLE OF CONTENTS
Committee Memberships | Other Public Co. Boards | ||||||||||||||||||||||||||||
Name | Age | Director Since | Tenure (Years) | Position with Fabrinet | Independent | AC | CC | NCGC | |||||||||||||||||||||
Nominees for Director | |||||||||||||||||||||||||||||
Seamus Grady | 59 | 2017 | 9 | Chief Executive Officer and Chairman of the Board | no | none | |||||||||||||||||||||||
Thomas F. Kelly | 73 | 2010 | 16 | Director | yes | Chair | ✔ | none | |||||||||||||||||||||
Continuing Directors | |||||||||||||||||||||||||||||
Forbes I.J. Alexander | 66 | 2024 | 2 | Director | yes | ✔ | ✔ | ✔ | none | ||||||||||||||||||||
Dr. Homa Bahrami | 71 | 2012 | 14 | Director | yes | ✔ | Chair | none | |||||||||||||||||||||
Caroline Dowling | 59 | 2025 | 1 | Director | yes | ✔ | ✔ | 2 | |||||||||||||||||||||
Dr. Frank H. Levinson | 73 | 2001 | 25 | Lead Independent Director | yes | ✔ | Chair | none | |||||||||||||||||||||
AC – Audit Committee | CC – Compensation Committee | NCGC – Nominating & Corporate Governance Committee | ||||||
![]() | 2026 PROXY STATEMENT | 15 | ||
TABLE OF CONTENTS
Nominees for Director: Terms to Expire in 2029 | ||
![]() | Seamus Grady Chief Executive Officer and Chairman of the Board Director since: September 2017 Age: 59 Board committees: None | ||
Board Skills and Qualifications • Deep knowledge of Fabrinet and the industries in which it operates • Broad and deep experience in the electronics manufacturing services industry, including overseeing operations at multiple international facilities | |||
Career Highlights • Chairman of the Board, Fabrinet (October 2025 – present) • Chief Executive Officer, Fabrinet (September 2017 – present) • Executive Vice President & Chief Operating Officer, Mechanical Systems Division, Sanmina Corporation, an electronics manufacturing services company (October 2012 to May 2017) • Various operations roles, Sanmina Corporation (2000-2012), including senior vice president medical division (June 2011 – October 2012) and senior vice president global medical operations (March 2009 to June 2011) • Prior operations roles at various companies, including Lucent Technologies Inc. and Manufacturers’ Services Limited (acquired by Celestica) | |||
Education • B. Tech in Manufacturing Technology from the National University of Ireland, Galway (NUIG) | |||
Other Public Company Boards (Last Five Years) • None | |||
16 | ![]() | 2026 PROXY STATEMENT | ||||
TABLE OF CONTENTS
![]() | Thomas F. Kelly Venture Consultant, Forgepoint Capital Director since: October 2010 Age: 73 Independent director Board committees: Audit (chair); Compensation | ||
Board Skills and Qualifications • More than 40 years of experience in executive management positions, with a strong focus on technology, operations and cybersecurity • Audit and financial reporting expertise | |||
Career Highlights • Venture Consultant, Forgepoint Capital, a venture capital firm (November 2022 – present) • Chief Executive Officer, Anitian, Inc., a Forgepoint Capital portfolio company and cloud security and compliance automation provider (February 2024 – November 2024) • Chief Executive Officer and President, IDX (acquired by ZeroFox Holdings, 2022), a provider of software and services for cyber breach and identity fraud protection (August 2017 – August 2022) • Cybersecurity industry consultant (2016 – 2017) • Chief Executive Officer of several software and security companies (1996 – 2016), including AccelOps (acquired by Fortinet, 2016), Moxie Software, MontaVista Software (acquired by Cavium, 2009), BlueStar Solutions (acquired by Affiliated Computer Services, 2004) and Blaze Software (acquired by Brokat Infosystems AG, 2000) • Prior executive leadership operating roles at several companies, including Epicor Software, Cirrus Logic, Cadence Design Systems, and Frame Technology (acquired by Adobe, 1995) | |||
Education • B.S. in Economics from Santa Clara University | |||
Other Public Company Boards (Last Five Years) • ZeroFox Holdings, Inc. (August 2022 – May 2024) | |||
![]() | 2026 PROXY STATEMENT | 17 | ||
TABLE OF CONTENTS
Continuing Directors: Terms Expire in 2027 | ||
![]() | Forbes I.J. Alexander Former Chief Financial Officer, Jabil Inc. Director since: June 2024 Age: 66 Independent director Board committees: Audit; Compensation; Nominating & Corporate Governance | ||
Board Skills and Qualifications • Extensive audit and financial reporting expertise and executive leadership experience in the electronics manufacturing services industry, having served as the Chief Financial Officer of Jabil Inc. for 14 years | |||
Career Highlights • Founding Partner, Steadfast Partners LLP, an industrial technology advisory group (January 2020 – present) • Executive Vice President, Jabil Inc., a global manufacturing services company (September 2018 – January 2020) • Chief Financial Officer, Jabil Inc. (September 2004 – August 2018) • Various other finance roles, Jabil Inc. (1993 – 2004) • Prior finance roles at various companies, including Tandy Electronics, Ltd., Octocom Systems U.K. Ltd and Apollo Computer (acquired by Hewlett-Packard in 1989) | |||
Education • B.A. in Accounting from Abertay University • Fellow of the Chartered Institute of Management Accountants (FCMA) | |||
Other Public Company Boards (Last Five Years) • None | |||
18 | ![]() | 2026 PROXY STATEMENT | ||||
TABLE OF CONTENTS
![]() | Dr. Frank H. Levinson General Partner, Convergent Ventures Director since: 2001 Age: 73 Lead Independent Director Board committees: Audit; Compensation (chair) | |||||
Board Skills and Qualifications • Extensive executive leadership and management experience, having served as Chief Executive Officer and Chairman of the Board at Finisar Corporation, which he co-founded • Deep technical expertise in the semiconductor industry | ||||||
Career Highlights • General Partner, Convergent Ventures, a venture capital firm focused on investing in science-driven technologies to change the future of health and sustainability (2023 – present) • Managing Director, Small World Group, a group primarily involved in investing in and growing small companies (2006 – 2025) • Chairman of the Board and Chief Technical Officer, Finisar Corporation (acquired by II-VI Incorporated), a provider of fiber optic components and network performance test and monitoring systems (August 1999 – January 2006) • Chief Executive Officer, Finisar Corporation (1988 – 1999) • Optical Department Manager, Raynet, Inc., a fiber optic systems company (1986 – 1988) • Prior technical roles at various companies, including Raychem Corporation, Bellcore, and AT&T Bell Laboratories | ||||||
Education • B.S. in Mathematics and Physics from Butler University • M.S. in Astronomy from the University of Virginia • Ph.D. in Astronomy from the University of Virginia | ||||||
Other Public Company Boards (Last Five Years) • TKB Critical Technologies 1, a special purpose acquisition company (October 2021 – August 2023) | ||||||
![]() | 2026 PROXY STATEMENT | 19 | ||
TABLE OF CONTENTS
Continuing Directors: Terms Expire in 2028 | ||
![]() | Dr. Homa Bahrami Senior Lecturer, Haas School of Business, University of California, Berkeley Director since: August 2012 Age: 71 Independent Director Board committees: Compensation; Nominating & Corporate Governance (chair) | ||
Board Skills and Qualifications • International educator, advisor and author, specializing in organizational design, dynamic leadership and executive development for global enterprises • Has served on the faculty at UC Berkeley for 40 years | |||
Career Highlights • Senior Lecturer, Haas School of Business, University of California, Berkeley (1995 – present) • Faculty Director, Haas Center for Executive Education (2006 – present) | |||
Education • B.A. in Sociology and Social Administration from the University of Hull • M.S. in Industrial Administration from Aston University • Ph.D. in Organizational Behavior from Aston University | |||
Other Public Company Boards (Last Five Years) • None | |||
20 | ![]() | 2026 PROXY STATEMENT | ||||
TABLE OF CONTENTS
![]() | Caroline Dowling Former Business Group President, Flex Director since: October 2025 Age: 59 Independent Director Board committees: Audit; Nominating & Corporate Governance | ||
Board Skills and Qualifications • Global business and technology leader with experience across manufacturing strategy, telecommunications and cloud infrastructure, M&A, business transformation, and complex global supply chains, together with public company board and governance experience • Over more than 20 years at Flex, led global teams and a group of Flex businesses with approximately $10 billion in annual revenue, bringing complex technologies from concept and design through to large-scale manufacturing and supply chains within a Fortune 500 company with operations in 30 countries | |||
Career Highlights • Business Group President, Flex, a top-tier electronic manufacturing services provider, where she led global businesses across telecommunications, networking, cloud and data center infrastructure, and services (2012 – February 2019) • Prior strategy, M&A, operations, business development and commercial leadership roles at Flex, including President of Corporate Strategy and Senior Vice President of Global Sales (2000 – 2012) • Prior business development, strategic account management and sales roles at DII Group (acquired by Flextronics) and Alps Electronics • Former board member, IDA Ireland | |||
Education • Completed the Harvard Advanced Management Program (AMP 175) • Holds a Diploma in Environmental, Social & Governance from the Corporate Governance Institute | |||
Other Public Company Boards (Last Five Years) • CRH plc (NYSE: CRH) (2021 – present); serves on the audit committee and the safety, environment & social responsibility committee • DCC plc (LSE: DCC) (2019 – present); Senior Independent Director; serves on the audit committee and the remuneration committee • IMI plc (LSE: IMI) (November 2019 – May 2025); chaired the remuneration committee and served on the nomination committee | |||
![]() | 2026 PROXY STATEMENT | 21 | ||
TABLE OF CONTENTS
Pay Element | Fiscal 2026 Board Compensation for Non-Employee Directors | |||||||
Annual Retainer (Cash) | All Board Members: | $85,000 | ||||||
Board Chair*: | $200,000 | |||||||
Lead Independent Director**: | $45,000 | |||||||
*Applicable only if the Board Chair is a non-employee director. | ||||||||
**Applicable only if the Board Chair is not an independent director. | ||||||||
Committee Member Retainer (Cash) | Audit Committee: | $14,000 (or $33,000 if member is the chair) | ||||||
Compensation Committee: | $10,000 (or $24,000 if member is the chair) | |||||||
Nominating & Corporate Governance Committee: | $7,000 (or $16,000 if member is the chair) | |||||||
Restricted Share Units (Equity) | Initial Grant*: Upon joining the Board, and effective as of the date an individual becomes a non-employee member of the Board, an award of RSUs, on a prorated basis, to cover a number of Fabrinet’s ordinary shares equal to: $220,000, divided by the closing price of the ordinary shares on the NYSE on the date of grant, and multiplied by the ratio of (i) the number of days beginning with the date the director joins the Board and ending on the day immediately preceding the one year anniversary of the prior year’s annual shareholder meeting, divided by (ii) 365 days, with the resulting number rounded up to the nearest whole share. For the avoidance of doubt, an individual who becomes a non-employee director as a result of ceasing to be an employee will be eligible to receive an Initial Grant. | |||||||
Annual Grant*: On the date of each annual shareholder meeting and provided that the non-employee director will continue as a Board member following such meeting, an award of RSUs covering a number of Fabrinet’s ordinary shares equal to: $220,000, divided by the closing price of the ordinary shares on the NYSE on the date of grant, with the resulting number rounded up to the nearest whole share. | ||||||||
Vesting: RSUs will be scheduled to vest in full on January 1 following the next annual meeting of shareholders after the applicable date of grant, provided the director continues to remain a service provider to Fabrinet through such date. | ||||||||
*Grants are automatic and nondiscretionary and subject to the terms and conditions of Fabrinet’s 2020 Equity Incentive Plan and form of Restricted Share Unit Agreement previously approved for use under such plan. Any RSUs that vest will be settled in ordinary shares of Fabrinet, and the par value of ordinary shares of Fabrinet issued upon such settlement will be considered to have been paid with past services rendered. | ||||||||
22 | ![]() | 2026 PROXY STATEMENT | ||||
TABLE OF CONTENTS
Name | Fees Earned or Paid in Cash ($) | Stock Awards ($)(1)(2)(3) | All Other Compensation ($) | Total ($) | ||||||||||
Current Non-Employee Directors | ||||||||||||||
Forbes I.J. Alexander | 108,500 | 220,247 | — | 328,747 | ||||||||||
Dr. Homa Bahrami | 111,000 | 220,247 | — | 331,247 | ||||||||||
Caroline Dowling(4) | 61,763 | 255,829 | — | 317,592 | ||||||||||
Thomas F. Kelly | 128,000 | 220,247 | — | 348,247 | ||||||||||
Dr. Frank H. Levinson | 168,000 | 220,247 | — | 388,247 | ||||||||||
Former Non-Employee Directors | ||||||||||||||
Darlene S. Knight(5) | 45,420 | — | — | 45,420 | ||||||||||
David T. (Tom) Mitchell(6) | 84,560 | — | — | 84,560 | ||||||||||
Rollance E. Olson(5) | 42,209 | — | 20,171(7) | 62,380 | ||||||||||
(1) | Reflects the aggregate grant date fair value of the shares in accordance with FASB Accounting Standards Codification Topic 718. The assumptions used in the valuation of these awards are set forth in the notes to our consolidated financial statements, which are included in our Annual Report on Form 10-K for fiscal 2026, filed with the SEC on August 18, 2026. These amounts do not correspond to the actual value that may be realized by the directors. |
(2) | In accordance with our non-employee director compensation program, upon her appointment to the Board (October 13, 2025) Ms. Dowling was granted 93 restricted share units with an aggregate grant date fair value of $35,582. On December 11, 2025, each of our current non-employee directors received an award of 417 restricted share units in accordance with our non-employee director compensation program. |
(3) | The following table presents the aggregate number of shares underlying unvested stock awards and outstanding options held by each of our non-employee directors as of the last day of fiscal 2026. Ms. Knight, Mr. Mitchell and Mr. Olson did not hold any unvested stock awards or outstanding options as of the last day of fiscal 2026. |
Name | Aggregate Number of Shares Underlying Unvested Stock Awards | Aggregate Number of Shares Underlying Outstanding Options | ||||||
Forbes I.J. Alexander | 417 | — | ||||||
Dr. Homa Bahrami | 417 | — | ||||||
Caroline Dowling | 417 | — | ||||||
Thomas F. Kelly | 417 | — | ||||||
Dr. Frank H. Levinson | 417 | — | ||||||
(4) | Appointed to the Board on October 13, 2025. |
(5) | Term ended at our 2025 annual general meeting of shareholders, held on December 11, 2025. |
(6) | Retired from the Board on October 13, 2025. |
(7) | Represents the cost of a Rolex watch given to Mr. Olson in recognition of years of service to Fabrinet. |
![]() | 2026 PROXY STATEMENT | 23 | ||
TABLE OF CONTENTS
24 | ![]() | 2026 PROXY STATEMENT | ||||
TABLE OF CONTENTS
![]() | 2026 PROXY STATEMENT | 25 | ||
TABLE OF CONTENTS
Board/Committee | No. of Meetings in Fiscal 2026 | ||||
Full Board | 7 | ||||
Audit | 4 | ||||
Compensation | 9 | ||||
Nominating & Corporate Governance | 5 | ||||
Total Meetings (average incumbent director attendance of 100%) | 25 | ||||
Executive Sessions of the Board (independent directors meet without management present) | 4 | ||||
26 | ![]() | 2026 PROXY STATEMENT | ||||
TABLE OF CONTENTS
![]() | 2026 PROXY STATEMENT | 27 | ||
TABLE OF CONTENTS
Position | Minimum Ownership Value | ||||
CEO | 6x annual base salary | ||||
Other Executive Officers | 3x annual base salary | ||||
Non-Employee Directors | 5x annual Board retainer | ||||
28 | ![]() | 2026 PROXY STATEMENT | ||||
TABLE OF CONTENTS
| the extent to which the director’s judgment, skills, qualifications and experience continue to contribute to the success of the Board and Fabrinet; |
| feedback from the annual Board evaluation and related discussions among the Board; |
| preparation for, and attendance and participation at, Board and committee meetings; |
| independence; |
| shareholder feedback, including the support received when the director last stood for election; and |
| outside board and other affiliations, including overboarding considerations, time commitments, and actual or perceived conflicts of interests. |
![]() | 2026 PROXY STATEMENT | 29 | ||
TABLE OF CONTENTS
30 | ![]() | 2026 PROXY STATEMENT | ||||
TABLE OF CONTENTS
• | Energy & Emissions: Site-level energy intensity targets guide investments in high-efficiency equipment, process automation, and employee conservation campaigns. |
• | Waste: Through our 3R (reduce, reuse, and recycle) Program, comprehensive waste separation facilitates assessment to continuously improve landfill diversion across manufacturing, office, and canteen facilities. |
• | Water: Use of closed-loop cooling, reuse of reverse-osmosis reject streams, and rain-harvesting to reduce freshwater withdrawals and increase recycled water use, reduces our natural resource use. |
• | Competitive compensation with profit-sharing, attendance bonuses, and a provident fund retirement program, along with comprehensive benefits and leave options. |
• | Employee development through Fabrinet Academy, an in-house education program offering training courses |
![]() | 2026 PROXY STATEMENT | 31 | ||
TABLE OF CONTENTS
• | Employee engagement enhanced through our Happy Workplace Program, quarterly all-hands meetings, milestone tenure awards, and numerous extracurricular activities. |
• | A commitment to an inclusive workplace that respects and values each employee, embracing and encouraging differences that make our employees unique, reinforced through a zero-tolerance approach to harassment, violence, or discrimination of any kind. |
32 | ![]() | 2026 PROXY STATEMENT | ||||
TABLE OF CONTENTS
• | We consult with experts on the best compensation and governance practices. |
• | We regularly attend and participate in investor roadshows and conferences. |
• | We reach out annually to our 25 largest shareholders, in advance of our annual shareholders’ meeting, and |
![]() | 2026 PROXY STATEMENT | 33 | ||
TABLE OF CONTENTS
Fiscal 2026 | Fiscal 2025 | |||||||
Audit Fees(1) | $1,709,768 | $1,663,562 | ||||||
Audit-Related Fees | — | — | ||||||
Tax Fees(2) | 57,140 | 53,750 | ||||||
All Other Fees(3) | 8,417 | 17,200 | ||||||
Total | $1,775,325 | $1,734,512 |
(1) | Audit Fees consist of fees for professional services provided in connection with the audit of our annual consolidated financial statements, the review of our quarterly consolidated financial statements, and audit services that are normally provided by the independent registered public accounting firm in connection with statutory and regulatory filings or engagements for the applicable fiscal year, such as statutory audits, as well as out of pocket expenses. |
(2) | Tax fees consist of fees for tax compliance services. |
(3) | All other fees consist of fees for accounting research software and accounting advisory services during the applicable fiscal year. |
34 | ![]() | 2026 PROXY STATEMENT | ||||
TABLE OF CONTENTS
![]() | 2026 PROXY STATEMENT | 35 | ||
TABLE OF CONTENTS
• | Reviewed and discussed the audited financial statements with management and with PricewaterhouseCoopers ABAS Ltd., our independent registered public accounting firm; |
• | Discussed with PricewaterhouseCoopers ABAS Ltd. the matters required to be discussed by the applicable requirements of the Public Company Accounting Oversight Board (the “PCAOB”) and the SEC; and |
• | Received the written disclosures and the letter from PricewaterhouseCoopers ABAS Ltd. required by applicable requirements of the PCAOB regarding PricewaterhouseCoopers ABAS Ltd.’s communications with the Audit Committee concerning independence, and has discussed with PricewaterhouseCoopers ABAS Ltd. its independence. |
36 | ![]() | 2026 PROXY STATEMENT | ||||
TABLE OF CONTENTS
Name | Age | Position | ||||||
Seamus Grady | 59 | Chief Executive Officer and Chairman of the Board | ||||||
Dr. Harpal Gill | 73 | President and Chief Operating Officer | ||||||
Csaba Sverha | 47 | Executive Vice President, Chief Financial Officer | ||||||
Edward T. Archer | 63 | Executive Vice President, Sales & Marketing | ||||||
![]() | 2026 PROXY STATEMENT | 37 | ||
TABLE OF CONTENTS
Name | Position | ||||
Seamus Grady | Chief Executive Officer (“CEO”) | ||||
Dr. Harpal Gill | President and Chief Operating Officer (“COO”) | ||||
Csaba Sverha | Executive Vice President, Chief Financial Officer (“CFO”) | ||||
Edward T. Archer | Executive Vice President, Sales & Marketing | ||||

38 | ![]() | 2026 PROXY STATEMENT | ||||
TABLE OF CONTENTS
Compensation Element | Decision | Weighting of Performance Measures | ||||||
Base salary | CEO’s annual base salary increased by 2.2%, as compared to fiscal 2025 Other NEO annual base salaries increased by between 2.3% and 5.6%, as compared to fiscal 2025 | N/A | ||||||
Short-term cash incentive (Fiscal 2026 Bonus Plan) | CEO’s target cash bonus opportunity was 140% of annual base salary, unchanged from fiscal 2025 Other NEO target cash bonus opportunities were 85%-130% of annual base salaries, unchanged from fiscal 2025 Maximum cash bonus opportunity for exceeding the target performance criteria remained at 120% of each NEO’s target bonus opportunity | Bonuses were payable after the end of fiscal 2026 as follows: • 50% based on achievement of a fiscal 2026 revenue metric • 50% based on achievement of a fiscal 2026 non-GAAP operating margin metric Minimum performance threshold for each metric was 90% of the target for such metric Maximum bonus opportunity was 120% of target bonus opportunity Achievement of a metric at a level between 90% and 100% of the applicable target metric would result in a payout scaled linearly from 20% to 100% of the target bonus opportunity Achievement of a metric at a level between 100% and 105% of the applicable target metric would result in a payout scaled linearly from 100% to 120% of the target bonus opportunity No individual performance component | ||||||
Long-term equity incentive (PSUs and RSUs) | PSUs have challenging two-year cumulative performance and “stretch” performance goals RSUs vest annually over three years Equity grants for all NEOs weighted heavily toward performance: 67% PSUs and 33% RSUs | The number of PSUs earned and eligible to vest will be determined after a two-year performance period as follows: • 50% based on achievement of cumulative fiscal 2026 and fiscal 2027 revenue goals • 50% based on achievement of cumulative fiscal 2026 and fiscal 2027 non-GAAP operating margin goals Any earned PSUs will vest in full on the date the Compensation Committee certifies achievement of the performance criteria | ||||||
![]() | 2026 PROXY STATEMENT | 39 | ||
TABLE OF CONTENTS
• | our executive officers’ cash and equity incentive compensation is subject to a claw back; |
• | we have a practice of granting long-term equity to our executive officers that is based, in part, on Fabrinet achieving financial performance goals over a two-year performance period; |
• | we maintain share ownership guidelines for our executive officers and directors; |
• | our employees (including our executive officers) and directors are prohibited from margining, short-selling or pledging our securities, or trading in derivative securities; |
• | we hold an annual shareholder advisory vote on executive compensation; and |
• | our 2020 Equity Incentive Plan (the “2020 Plan”) contains the following features: |
° | we are prohibited from instituting any program to reprice or exchange equity awards for awards with a lower exercise price without shareholder approval; |
° | we are prohibited from “recycling” shares, which means that any shares subject to a grant are counted |
° | all awards under the plan are subject to the participant’s continued employment or other service with us and vest over a four-year period, unless otherwise set forth in the award agreement; |
° | we are prohibited from paying dividends with respect to an award prior to the vesting of such award; |
° | we are prohibited from granting awards that may vest or become exercisable earlier than one year after such award is granted, except that awards up to a maximum of five percent (5%) of the total shares reserved and available for grant and issuance under the plan may be granted without regard to such minimum one-year vesting requirements; and |
° | we are prohibited from accelerating the vesting of an award before the one-year anniversary of the award’s grant date, except in connection with death, disability, termination of employment, reaching retirement age or an event that triggers the plan’s provisions relating to assumption and termination of awards. |
• | Competition. We should provide competitive compensation opportunities with respect to our industry so we can attract, retain and motivate qualified executives. |
• | Alignment with Shareholder Interests. A substantial portion of compensation should be contingent on our performance for our shareholders, to align the interests of executives with the interests of our shareholders and to hold the executives accountable for our performance. |
40 | ![]() | 2026 PROXY STATEMENT | ||||
TABLE OF CONTENTS
Compensation Element | Compensation Objectives Designed to be Achieved | ||||
Base salary | Attract, retain and motivate qualified executives. | ||||
Short-term cash incentives | Align executives’ interests with those of shareholders; Hold executives accountable for our performance; and Attract, retain and motivate qualified executives. | ||||
Long-term equity incentives | Align executives’ interests with those of shareholders; Hold executives accountable for our performance; and Attract, retain and motivate qualified executives. | ||||
Perquisites and personal benefits | Attract, retain and motivate qualified executives. | ||||
Severance and other benefits upon termination of employment | Attract, retain and motivate qualified executives. | ||||
![]() | 2026 PROXY STATEMENT | 41 | ||
TABLE OF CONTENTS
42 | ![]() | 2026 PROXY STATEMENT | ||||
TABLE OF CONTENTS
Fiscal 2026 Peer Group | |||||||||||
Advanced Energy Industries, Inc. | Coherent Corporation | Littelfuse, Inc. | Qorvo, Inc. | ||||||||
Amkor Technology, Inc. | Entegris, Inc. | Lumentum Holdings Inc. | Sanmina Corporation | ||||||||
Belden Inc. | F5, Inc. | MKS Instruments, Inc. | Skyworks Solutions, Inc. | ||||||||
Celestica Inc. | IPG Photonics Corporation | Novanta Inc. | Trimble Inc. | ||||||||
Ciena Corporation | Jabil Inc. | Plexus Corporation | Zebra Technologies Corporation | ||||||||
Name | Fiscal 2025 Annual Base Salary | Fiscal 2026 Annual Base Salary | % Change | ||||||||
Seamus Grady | $1,350,000 | $1,380,000 | 2.2% | ||||||||
Dr. Harpal Gill | $1,100,000 | $1,125,000 | 2.3% | ||||||||
Csaba Sverha | $625,000(1) | THB 24,380,400(2) | 5.6%(3) | ||||||||
Edward T. Archer | $520,000 | $540,000 | 3.8% |
(1) | Mr. Sverha’s fiscal 2025 annual base salary was approved in U.S. dollars and paid in his home currency of Thai baht using the Fabrinet Corporate Group USD to THB Exchange Rate, which was the Bank of Thailand’s middle rate (midpoint of the bid and ask rates) as of June 28, 2024, of 1.0 U.S. dollar to 36.94 Thai baht. This resulted in a fiscal 2025 salary for Mr. Sverha of 23,087,500 Thai baht. |
(2) | Mr. Sverha is based in Thailand. Beginning with Mr. Sverha’s fiscal 2026 annual base salary, the Compensation Committee approves Mr. Sverha’s salary in Thai baht and considers adjustments to Mr. Sverha’s salary as a percentage of his existing salary as denominated in Thai baht. Converting Mr. Sverha’s fiscal 2026 salary into U.S. dollars results in a salary of $750,628, using the Fabrinet Corporate Group THB to USD Exchange Rate, which was the Bank of Thailand’s middle rate (midpoint of the bid and ask rates) as of June 26, 2025, of 32.48 Thai baht to 1 U.S. dollar. |
(3) | Percentage increase is based on Mr. Sverha’s fiscal 2025 annual base salary in Thai baht. See footnotes (1) and (2) above. |
![]() | 2026 PROXY STATEMENT | 43 | ||
TABLE OF CONTENTS
• | payouts are based 50% on achievement of a fiscal year revenue metric and 50% on achievement of a fiscal year non-GAAP operating margin metric, with achievement of each financial metric considered independently from the other; |
• | performance targets are equal to our annual operating plan targets, which the Compensation Committee believes should be realistic and achievable; |
• | the minimum performance threshold for each metric is 90% of the target for such metric; |
• | the maximum bonus opportunity is 120% of the target bonus opportunity; |
• | achievement of a financial metric at a level between 90% and 100% of the applicable target financial metric results in a payout scaled linearly from 20% to 100% of the target bonus opportunity for that metric; and |
• | achievement of a financial metric at a level between 100% and 105% of the applicable target financial metric would result in a payout scaled linearly from 100% to 120% of the target bonus opportunity for that metric. |
Performance Metric | Weight | Minimum Threshold(1) | Target(2) | Maximum(3) | Actual Performance | Actual Performance (% of Target) | ||||||||||||||
Revenue | 50% | $3,600.0 | $4,000.0 | $4,200.0 | $4,641.1 | 116.0% | ||||||||||||||
Non-GAAP Operating Margin(4) | 50% | 8.91% | 9.9% | 10.4% | 10.77% | 108.8% |
(1) | Below this amount, no bonuses would have been earned with respect to the applicable performance metric. |
(2) | Achievement of this goal would have resulted in a payout at 100% of a participant’s target bonus opportunity for the applicable performance metric. |
(3) | Represents 105% of the applicable target performance goal. Achievement of this goal would have resulted in a maximum payout at 120% of a participant’s target bonus opportunity for the applicable performance metric. |
(4) | Non-GAAP operating margin excluded share-based compensation expenses, severance payment and others, legal and litigation costs, restructuring and other related costs, non-marketable equity securities revaluation, and charges arising from the implementation or application of the OECD Pillar Two global minimum tax framework, including charges resulting from changes in implementing regulations, administrative guidance or related governmental measures, as shown on Appendix A. |
44 | ![]() | 2026 PROXY STATEMENT | ||||
TABLE OF CONTENTS
Name | FY26 Target Bonus Opportunity | FY26 Target Bonus Opportunity (% of Salary) | FY26 Maximum Bonus Opportunity | FY26 Maximum Bonus Opportunity (% of Salary) | FY26 Actual Bonus | FY26 Actual Bonus (% of Target Bonus Opportunity) | ||||||||||||||
Seamus Grady | $1,932,000 | 140% | $2,318,400 | 168% | $2,318,400 | 120% | ||||||||||||||
Dr. Harpal Gill | $1,462,500 | 130% | $1,755,000 | 156% | $1,755,000 | 120% | ||||||||||||||
Csaba Sverha | THB 24,380,400 | 100% | THB 29,256,480 | 120% | THB 29,256,480 | 120% | ||||||||||||||
Edward T. Archer | $459,000 | 85% | $550,800 | 102% | $550,800 | 120% |
Name | % of FY26 Performance-Based Equity Awards (PSUs) | % of FY26 Time-Based Equity Awards (RSUs) | ||||||
Mr. Grady | 67% | 33% | ||||||
Dr. Gill | 67% | 33% | ||||||
Mr. Sverha | 67% | 33% | ||||||
Mr. Archer | 67% | 33% |
![]() | 2026 PROXY STATEMENT | 45 | ||
TABLE OF CONTENTS
Name | Number of Shares Subject to Time-Based RSUs | Intended Value of Time-Based RSUs(1) | Number of Shares Subject to PSUs | Intended Value of PSUs at Maximum Level of Performance(1) | Number of Shares Subject to “Stretch” PSUs | Intended Value of “Stretch” PSUs at Maximum Level of Performance(1) | ||||||||||||||
Seamus Grady | 11,371 | $3,150,000 | 11,371 | $3,150,000 | 11,371 | $3,150,000 | ||||||||||||||
Dr. Harpal Gill | 6,245 | $1,730,000 | 6,245 | $1,730,000 | 6,245 | $1,730,000 | ||||||||||||||
Csaba Sverha | 3,754 | $1,040,000 | 3,754 | $1,040,000 | 3,754 | $1,040,000 | ||||||||||||||
Edward T. Archer | 3,033 | $840,000 | 3,033 | $840,000 | 3,033 | $840,000 |
(1) | The intended value of each of these equity awards was converted into a number of shares subject to the applicable RSUs, PSUs or Stretch PSUs by dividing the intended value by $277.04, the closing price per share of our ordinary shares on the NYSE on the date of grant, and rounding up to the nearest whole share. |
46 | ![]() | 2026 PROXY STATEMENT | ||||
TABLE OF CONTENTS
![]() | 2026 PROXY STATEMENT | 47 | ||
TABLE OF CONTENTS
FY25-26 Base PSUs | |||||||||||||||||
Name | Date of Grant | Target (and Maximum) Number of Shares That Could Have Vested for FY25-26 Cycle | Actual Number of Shares Vested for FY25-26 Cycle | Performance Measures for FY25-26 Cycle | Actual Performance for FY25-26 Cycle | ||||||||||||
Mr. Grady | 8/22/2024 | 10,121 | 10,121 | 10% to 50% vesting based on achievement of revenue between $5,664.2 million and $6,293.5 million 10% to 50% vesting based on achievement of non-GAAP operating margin between 9.2% and 10.2% | Revenue of $8,060.4 million Non-GAAP operating margin of 10.679% | ||||||||||||
Dr. Gill | 8/22/2024 | 6,493 | 6,493 | ||||||||||||||
Mr. Sverha | 8/22/2024 | 3,820 | 3,820 | ||||||||||||||
Mr. Archer | 8/22/2024 | 3,056 | 3,056 | ||||||||||||||
FY25-26 Stretch PSUs | |||||||||||||||||
Name | Date of Grant | Target (and Maximum) Number of Shares That Could Have Vested for FY25-26 Cycle | Actual Number of Shares Vested for FY25-26 Cycle | Performance Measures for FY25-26 Cycle | Actual Performance for FY25-26 Cycle | ||||||||||||
Mr. Grady | 8/22/2024 | 10,121 | 9,908 | 0% to 50% vesting based on achievement of revenue between $6,293.5 million and $6,608.2 million 0% to 50% vesting based on achievement of non-GAAP operating margin between 10.2% and 10.7% | Revenue of $8,060.4 million Non-GAAP operating margin of 10.679% | ||||||||||||
Dr. Gill | 8/22/2024 | 6,493 | 6,356 | ||||||||||||||
Mr. Sverha | 8/22/2024 | 3,820 | 3,739 | ||||||||||||||
Mr. Archer | 8/22/2024 | 3,056 | 2,991 | ||||||||||||||
48 | ![]() | 2026 PROXY STATEMENT | ||||
TABLE OF CONTENTS
![]() | 2026 PROXY STATEMENT | 49 | ||
TABLE OF CONTENTS
Name and Principal Position | Fiscal Year | Salary ($) | Stock Awards ($)(1)(2) | Non-Equity Incentive Plan Compensation ($)(3) | All Other Compensation ($)(4) | Total ($) | ||||||||||||||
Seamus Grady Chief Executive Officer | 2026 | 1,380,000 | 9,450,666 | 2,318,400 | 453,383 | 13,602,449 | ||||||||||||||
2025 | 1,350,000 | 7,950,249 | 2,208,654 | 435,232 | 11,944,135 | |||||||||||||||
2024 | 1,250,000 | 7,799,780 | 1,944,313 | 88,098 | 11,082,191 | |||||||||||||||
Dr. Harpal Gill President and Chief Operating Officer | 2026 | 1,125,000 | 5,190,345 | 1,755,000 | 1,223,670 | 9,294,015 | ||||||||||||||
2025 | 1,100,000 | 5,100,381 | 1,671,098 | 2,156,467 | 10,027,946 | |||||||||||||||
2024 | 1,060,000 | 4,874,564 | 1,648,777 | 1,342,592 | 8,925,933 | |||||||||||||||
Csaba Sverha(5) Executive Vice President, Chief Financial Officer | 2026 | 750,628 | 3,120,024 | 900,754 | 295,168 | 5,066,574 | ||||||||||||||
2025 | 625,000 | 3,000,687 | 730,375 | 273,635 | 4,629,697 | |||||||||||||||
2024 | 590,000 | 2,699,722 | 600,045 | 229,114 | 4,118,881 | |||||||||||||||
Edward T. Archer Executive Vice President, Sales & Marketing | 2026 | 540,000 | 2,520,786 | 550,800 | 84,581 | 3,696,167 | ||||||||||||||
2025 | 520,000 | 2,400,549 | 516,521 | 87,907 | 3,524,977 | |||||||||||||||
2024 | 510,000 | 2,249,689 | 488,172 | 87,498 | 3,335,359 | |||||||||||||||
(1) | The amounts in this column include the aggregate grant date fair value (computed in accordance with FASB ASC Topic 718) of time-based RSU awards granted during the designated fiscal year. The assumptions used in the valuation of these awards are set forth in the notes to our consolidated financial statements, which are included in our Annual Report on Form 10-K for our fiscal year ended June 26, 2026, filed with the SEC on August 18, 2026. These amounts do not necessarily correspond to the actual value that may be recognized by the Named Officer. |
(2) | The amounts in this column also include the value at the grant date of performance-based RSUs (PSUs) granted during the designated fiscal year based upon the probable outcome of the performance conditions for such awards, consistent with the estimate of aggregate compensation cost to be recognized over the service period determined as of the grant date under FASB ASC Topic 718, excluding the effect of estimated forfeitures. |
Name | Maximum Value of PSUs and “Stretch” PSUs Granted in Fiscal 2026 (FY26-27 Performance Period) | ||||
Seamus Grady | 6,300,444 | ||||
Dr. Harpal Gill | 3,460,230 | ||||
Csaba Sverha | 2,080,016 | ||||
Edward T. Archer | 1,680,524 | ||||
(3) | The amounts in this column reflect cash bonuses earned under our cash-based incentive plan for the applicable fiscal year. Amounts earned under our Fiscal 2026 Bonus Plan are reported as compensation for fiscal 2026 but were paid in fiscal 2027. Amounts earned under our Fiscal 2025 Bonus Plan are reported as compensation for fiscal 2025 but were paid in fiscal 2026. Amounts earned under our fiscal 2024 cash-based incentive plan are reported as compensation for fiscal 2024 but were paid in fiscal 2025. For more information, see the “Grants of Plan-Based Awards in Fiscal 2026” table below. |
(4) | For more information, see the “All Other Compensation for Fiscal 2026” table below. |
(5) | Mr. Sverha is based in Thailand. Mr. Sverha’s fiscal 2024 and fiscal 2025 salary, non-equity incentive plan compensation, and certain amounts reported in the “All Other Compensation” column were approved in U.S. dollars, but paid in his home country currency of Thai baht. Mr. Sverha’s fiscal 2026 salary, non-equity incentive plan compensation, and certain amounts reported in the “All Other Compensation” column were approved and paid in his home country currency of Thai baht. Fiscal 2026 amounts were converted from Thai baht to U.S. dollars using the Fabrinet Corporate Group THB to USD Exchange Rate, which was the Bank of Thailand’s middle rate (midpoint of the bid and ask rates) as of June 26, 2025, of 32.48 Thai baht to 1 U.S. dollar. |
50 | ![]() | 2026 PROXY STATEMENT | ||||
TABLE OF CONTENTS
Name | Transportation ($)(1) | Housing ($)(2) | Tax Equalization Payment ($)(3) | Foreign Service Premium Pay ($)(4) | Health Insurance Premiums ($) | Company- Paid 401(k) or Provident Fund Contributions ($) | Total ($) | ||||||||||||||||
Seamus Grady | 41,797 | 300,000 | — | — | 89,986 | 21,600 | 453,383 | ||||||||||||||||
Dr. Harpal Gill | 90,707 | 120,000 | 722,979 | 225,000 | 40,577 | 24,407 | 1,223,670 | ||||||||||||||||
Csaba Sverha | 45,209 | 120,000 | — | — | 61,906 | 68,053 | 295,168 | ||||||||||||||||
Edward T. Archer | 18,056 | — | — | — | 44,924 | 21,601 | 84,581 | ||||||||||||||||
(1) | For Mr. Grady, represents (i) an annual automobile allowance of $12,000 ($17,824, inclusive of tax gross-up) and (ii) $23,973 of expenses related to a car and driver in Thailand. For Dr. Gill, represents (i) an annual travel allowance of $25,000 ($47,304, inclusive of tax gross-up), (ii) an annual automobile allowance of $12,000, and (iii) $31,403 of expenses related to a car and driver in Thailand. For Mr. Sverha, represents expenses related to a car and driver in Thailand. For Mr. Archer, represents an annual automobile allowance of $12,000 ($18,056, inclusive of tax gross-up). |
(2) | Represents an annual cash allowance for housing and related living expenses in Thailand. |
(3) | Represents foreign tax liability payments by Fabrinet on Dr. Gill’s behalf to satisfy his applicable non-U.S. taxes for calendar years 2024 and 2025. Tax equalization benefits for any future years may differ substantially from this amount. Consistent with corporate policy, we pay on behalf of all U.S. citizens who are working on our behalf in Asia on an expatriate basis a tax equalization payment that is intended to put the employee in the same position, from a tax-liability perspective, that he or she would be in if they were still located in the United States. |
(4) | Represents additional cash compensation in the amount of 20% of Dr. Gill’s annual base salary, with a tax gross-up, to incentivize him to continue working for us in Thailand and ameliorate the resulting hardship to his family, which is located in the United States. |
![]() | 2026 PROXY STATEMENT | 51 | ||
TABLE OF CONTENTS
Estimated Possible Payouts Under Non-Equity Incentive Plan Awards(1) | Estimated Possible Payouts Under Equity Incentive Plan Awards(2) | All Other Stock Awards: Number of Shares of Stock or Units (#) | Grant Date Fair Value of Stock Awards ($)(3) | ||||||||||||||||||||||||||||||||
Name | Grant Date | Approval Date | Type of Award | Threshold ($) | Target ($) | Maximum ($) | Threshold (#) | Target (#) | Maximum (#) | ||||||||||||||||||||||||||
Seamus Grady | — | — | FY26 Bonus Plan | 193,200 | 1,932,000 | 2,318,400 | — | — | — | — | — | ||||||||||||||||||||||||
8/21/2025 | 8/12/2025 | RSU(4) | — | — | — | — | — | — | 11,371 | 3,150,222 | |||||||||||||||||||||||||
8/21/2025 | 8/12/2025 | PSU(4) | — | — | — | 1,137 | 11,371 | 11,371 | — | 3,150,222 | |||||||||||||||||||||||||
8/21/2025 | 8/12/2025 | “Stretch” PSU(4) | — | — | — | — | 11,371 | 11,371 | — | 3,150,222 | |||||||||||||||||||||||||
Dr. Harpal Gill | — | — | FY26 Bonus Plan | 146,250 | 1,462,500 | 1,755,000 | — | — | — | — | — | ||||||||||||||||||||||||
8/21/2025 | 8/12/2025 | RSU(4) | — | — | — | — | — | — | 6,245 | 1,730,115 | |||||||||||||||||||||||||
8/21/2025 | 8/12/2025 | PSU(4) | — | — | — | 625 | 6,245 | 6,245 | — | 1,730,115 | |||||||||||||||||||||||||
8/21/2025 | 8/12/2025 | “Stretch” PSU(4) | — | — | — | — | 6,245 | 6,245 | — | 1,730,115 | |||||||||||||||||||||||||
Csaba Sverha | — | — | FY26 Bonus Plan | 75,063 | 750,628 | 900,754 | — | — | — | — | — | ||||||||||||||||||||||||
8/21/2025 | 8/12/2025 | RSU(4) | — | — | — | — | — | — | 3,754 | 1,040,008 | |||||||||||||||||||||||||
8/21/2025 | 8/12/2025 | PSU(4) | — | — | — | 375 | 3,754 | 3,754 | — | 1,040,008 | |||||||||||||||||||||||||
8/21/2025 | 8/12/2025 | “Stretch” PSU(4) | — | — | — | — | 3,754 | 3,754 | — | 1,040,008 | |||||||||||||||||||||||||
Edward T. Archer | — | — | FY26 Bonus Plan | 45,900 | 459,000 | 550,800 | — | — | — | — | — | ||||||||||||||||||||||||
8/21/2025 | 8/12/2025 | RSU(4) | — | — | — | — | — | — | 3,033 | 840,262 | |||||||||||||||||||||||||
8/21/2025 | 8/12/2025 | PSU(4) | — | — | — | 303 | 3,033 | 3,033 | — | 840,262 | |||||||||||||||||||||||||
8/21/2025 | 8/12/2025 | “Stretch” PSU(4) | — | — | — | — | 3,033 | 3,033 | — | 840,262 | |||||||||||||||||||||||||
(1) | Amounts reported represent the potential threshold, target and maximum cash incentive award amounts depending on the level of performance achieved under the Fiscal 2026 Bonus Plan, as described in “Executive Compensation—Compensation Discussion and Analysis—Executive Compensation Program Elements—Short-Term Cash Incentive Awards” above. Such amounts ranged from 10% of the target payout, representing the lowest payout that would have been awarded upon achievement of a certain level of performance against one of the two financial goals under the Fiscal 2026 Bonus Plan, to 120% of the target payout, which represented the maximum payout possible under the Fiscal 2026 Bonus Plan. In August 2026, the Compensation Committee determined that we exceeded the maximum pre-established performance targets under the Fiscal 2026 Bonus Plan and awarded the maximum bonus amounts, equal to 120% of each participant’s target bonus opportunity. The actual bonus amounts that were awarded are reflected in the “Non-Equity Incentive Plan Compensation” column of the “Summary Compensation Table” above. |
(2) | Amounts reported represent the potential threshold, target and maximum number of shares the Named Officer could earn pursuant to his PSU and “Stretch” PSU awards based on achievement of two-year corporate performance objectives covering fiscal 2026 and fiscal 2027. If we achieve a threshold performance level of 90% of one of two target financial goals, the PSUs will vest as to 20% of the PSUs allocated to that financial goal (i.e., 10% of the total number of PSUs). There is no threshold payout amount under the “Stretch” PSUs because we must exceed at least one of the target financial goals under the PSUs in order for any portion of the “Stretch” PSUs to vest. There is no overlap between the performance measures for PSUs and “Stretch” PSUs. For more information, see “Executive Compensation—Compensation Discussion and Analysis—Executive Compensation Program Elements—Long-Term Equity Incentive Awards” above. |
(3) | Reflects the aggregate grant date fair value of each equity award computed in accordance with FASB ASC Topic 718. Amounts reported for PSUs and “Stretch” PSUs are based upon the probable outcome of the performance conditions, consistent with the estimate of aggregate compensation cost to be recognized over the service period determined as of the grant date under FASB ASC Topic 718, excluding the effects of estimated forfeitures. As of the date of grant, the probable outcome of the performance conditions for these grants was 100% achievement. The reported amounts do not necessarily correspond to the actual value that may be recognized by the Named Officer. |
(4) | Granted under our 2020 Equity Incentive Plan. |
52 | ![]() | 2026 PROXY STATEMENT | ||||
TABLE OF CONTENTS
Stock Awards | |||||||||||||||||
Name | Grant Date | Number of Shares or Units of Stock That Have Not Vested (#)(1) | Market Value of Shares or Units of Stock That Have Not Vested ($)(2) | Equity Incentive Plan Awards: Number of Unearned Shares or Units of Stock That Have Not Vested (#)(3) | Equity Incentive Plan Awards: Market Value of Unearned Shares or Units of Stock That Have Not Vested ($)(4) | ||||||||||||
Seamus Grady | 8/21/2025 | 11,371 | 5,967,387 | — | — | ||||||||||||
8/21/2025(5) | — | — | 11,371(6) | 5,967,387 | |||||||||||||
8/21/2025(5) | — | — | 11,371(6) | 5,967,387 | |||||||||||||
8/22/2024 | 6,748 | 3,541,283 | — | — | |||||||||||||
8/22/2024(7) | — | — | 10,121(8) | 5,311,400 | |||||||||||||
8/22/2024(7) | — | — | 10,121(9) | 5,311,400 | |||||||||||||
8/24/2023 | 5,454 | 2,862,205 | — | — | |||||||||||||
Dr. Harpal Gill | 8/21/2025 | 6,245 | 3,277,314 | — | — | ||||||||||||
8/21/2025(5) | — | — | 6,245(6) | 3,277,314 | |||||||||||||
8/21/2025(5) | — | — | 6,245(6) | 3,277,314 | |||||||||||||
8/22/2024 | 4,329 | 2,271,816 | — | — | |||||||||||||
8/22/2024(7) | — | — | 6,493(8) | 3,407,461 | |||||||||||||
8/22/2024(7) | — | — | 6,493(9) | 3,407,461 | |||||||||||||
8/24/2023 | 3,409 | 1,789,009 | — | — | |||||||||||||
Csaba Sverha | 8/21/2025 | 3,754 | 1,970,062 | — | — | ||||||||||||
8/21/2025(5) | — | — | 3,754(6) | 1,970,062 | |||||||||||||
8/21/2025(5) | — | — | 3,754(6) | 1,970,062 | |||||||||||||
8/22/2024 | 2,547 | 1,336,640 | — | — | |||||||||||||
8/22/2024(7) | — | — | 3,820(8) | 2,004,698 | |||||||||||||
8/22/2024(7) | — | — | 3,820(9) | 2,004,698 | |||||||||||||
8/24/2023 | 1,888 | 990,804 | — | — | |||||||||||||
Edward T. Archer | 8/21/2025 | 3,033 | 1,591,688 | — | — | ||||||||||||
8/21/2025(5) | — | — | 3,033(6) | 1,591,688 | |||||||||||||
8/21/2025(5) | — | — | 3,033(6) | 1,591,688 | |||||||||||||
8/22/2024 | 2,038 | 1,069,522 | — | — | |||||||||||||
8/22/2024(7) | — | — | 3,056(8) | 1,603,758 | |||||||||||||
8/22/2024(7) | — | — | 3,056(9) | 1,603,758 | |||||||||||||
8/24/2023 | 1,573 | 825,495 | — | — | |||||||||||||
(1) | Stock awards in this column consist of unvested time-based RSUs. Unless otherwise noted, all time-based RSUs are scheduled to vest over a three-year period at a rate of one-third on each anniversary of the grant date, subject to continued service with us through the applicable vesting date. |
(2) | Values reported were determined by multiplying the number of unvested time-based RSUs by $524.79, the closing price on the NYSE of our ordinary shares on June 26, 2026, the last business day of fiscal 2026. |
(3) | Amounts reported assume achievement in full of performance measures under PSU and “Stretch” PSU awards. |
(4) | Values reported determined by multiplying the number of unvested PSUs and “Stretch” PSUs (assuming achievement in full of performance measures) by $524.79, the closing price on the NYSE of our ordinary shares on June 26, 2026, the last business day of fiscal 2026. |
(5) | The performance cycle for this award began on June 28, 2025 and ends on June 25, 2027 (the “fiscal 2026-2027 cycle”). |
(6) | This award will vest, if at all, following the end of the fiscal 2026-2027 cycle, on the date the Compensation Committee certifies achievement of the applicable performance criteria. |
(7) | The performance cycle for this award began on June 29, 2024 and ended on June 26, 2026 (the “fiscal 2025-2026 cycle”). |
(8) | In August 2026, 100% of the shares subject to this award vested following the Compensation Committee’s certification of achievement of the performance criteria for the fiscal 2025-2026 cycle. |
(9) | In August 2026, 97.9% of the shares subject to this award vested and 2.1% of the shares subject to this award were forfeited following the Compensation Committee’s certification of achievement of the performance criteria for the fiscal 2025-2026 cycle. |
![]() | 2026 PROXY STATEMENT | 53 | ||
TABLE OF CONTENTS
Option Awards | Stock Awards | |||||||||||||
Name | Number of Shares Acquired on Exercise (#) | Value Realized on Exercise ($) | Number of Shares Acquired on Vesting (#) | Value Realized on Vesting ($)(1) | ||||||||||
Seamus Grady | — | — | 48,650 | 16,319,161 | ||||||||||
Dr. Harpal Gill | — | — | 30,780 | 10,319,904 | ||||||||||
Csaba Sverha | — | — | 16,902 | 5,665,621 | ||||||||||
Edward T. Archer | — | — | 14,160 | 4,747,292 | ||||||||||
(1) | The value realized on vesting was determined by multiplying (i) the number of our ordinary shares acquired upon vesting of stock-based awards, by (ii) the closing price per share of our ordinary shares on the NYSE on the applicable vesting date. |
54 | ![]() | 2026 PROXY STATEMENT | ||||
TABLE OF CONTENTS
| a lump sum payment of 100% of his annual base salary as of the date of employment termination; |
| a lump sum payment of any earned but unpaid bonus as of the date of employment termination; |
| a lump sum payment of two times his cost of COBRA coverage for twelve months; and |
| to the extent Mr. Grady is receiving tax equalization benefits under our expatriate policy as of the date of employment termination, continued tax equalization benefits for the calendar year in which the employment termination occurs and the immediately following calendar year. |
![]() | 2026 PROXY STATEMENT | 55 | ||
TABLE OF CONTENTS
| a lump sum payment of 200% of his annual base salary as of the date of employment termination (or, if greater, his annual base salary as in effect immediately before the change in control); |
| a lump sum payment of any earned but unpaid bonus as of the date of employment termination; |
| a lump sum payment of 200% of his annual target bonus opportunity in effect as of the date of employment termination (or, if greater, his annual target bonus opportunity as in effect immediately before the change in control); |
| a lump sum payment of two times his cost of COBRA coverage for twelve months; |
| 100% vesting acceleration of any unvested and outstanding time-based equity awards (i.e., awards subject to vest based on continued service but not any other performance requirements); and |
| to the extent Mr. Grady is receiving tax equalization benefits under our expatriate policy as of the date of employment termination, continued tax equalization benefits for the calendar year in which the employment termination occurs and the immediately following calendar year. |
| a lump sum payment equal to one month’s base salary as of the date of employment termination multiplied by the total number of full and fractional years of his employment with us as of the date of employment termination; |
| a lump sum payment of any earned but unpaid bonus as of the date of employment termination; |
| a lump sum payment of two times his cost of COBRA coverage for twelve months; |
| 100% vesting acceleration of any then-outstanding and unvested time-based restricted stock unit awards (i.e., awards subject to vest based on continued service but not any other performance requirements); |
| any then-outstanding and unvested performance-based equity awards that remain subject to the achievement of any performance goals as of the date of employment termination will remain outstanding and eligible to vest based on the extent that the applicable performance-based or other criteria are satisfied (see “—Treatment of Performance-Based Awards in Change in Control” below); and |
| continued tax equalization benefits under our expatriate policy, as in effect on the date of employment termination, for the calendar year in which the employment termination occurs and the immediately following calendar year. |
56 | ![]() | 2026 PROXY STATEMENT | ||||
TABLE OF CONTENTS
| a lump sum payment equal to one month’s base salary as of the date of employment termination multiplied by the total number of full and fractional years of his employment with us as of the date of employment termination; |
| a lump sum payment of any earned but unpaid bonus as of the date of employment termination; |
| a lump sum payment of two times his cost of COBRA coverage for twelve months; |
| 100% vesting acceleration of any then-outstanding and unvested time-based restricted stock unit awards (i.e., awards subject to vest based on continued service but not any other performance requirements); and |
| any then-outstanding and unvested performance-based equity awards that remain subject to the achievement of any performance goals as of the date of employment termination will remain outstanding and eligible to vest based on the extent that the applicable performance-based or other criteria are satisfied (see “—Treatment of Performance-Based Awards in Change in Control” below). |
| a lump sum payment of 50% of the participant’s annual base salary as of the date of employment termination; |
| a lump sum payment equal to the participant’s earned but unpaid bonus as of the date of employment termination; |
| a lump sum payment of 18 times the monthly premium for continued health coverage under COBRA for the participant and the participant’s eligible dependents, as applicable; and |
| to the extent a participant is receiving tax equalization benefits under our expatriate policy as of the date of employment termination, continued tax equalization benefits for the calendar year in which the employment termination occurs and the immediately following calendar year. |
![]() | 2026 PROXY STATEMENT | 57 | ||
TABLE OF CONTENTS
| a lump sum payment of 100% of the participant’s annual base salary as of the date of employment termination (or, if greater, the participant’s annual base salary as in effect immediately before the change in control); |
| a lump sum payment of any earned but unpaid bonus as of the date of employment termination; |
| a lump sum payment of 100% of the participant’s annual target bonus opportunity in effect as of the date of employment termination (or, if greater, the participant’s annual target bonus opportunity as in effect immediately before the change in control); |
| a lump sum payment of 18 times the monthly premium for continued health coverage under COBRA for the participant and the participant’s eligible dependents, as applicable; |
| 100% vesting acceleration of any unvested and outstanding time-based equity awards (i.e., awards subject to vest based on continued service but not any other performance requirements) (“Time-Based Awards”); and |
| to the extent a participant is receiving tax equalization benefits under our expatriate policy as of the date of employment termination, continued tax equalization benefits for the calendar year in which the employment termination occurs and the immediately following calendar year. |
58 | ![]() | 2026 PROXY STATEMENT | ||||
TABLE OF CONTENTS
![]() | 2026 PROXY STATEMENT | 59 | ||
TABLE OF CONTENTS
Name | Type of Benefit | Due to Death ($) | Due to Disability ($) | Without Cause ($) | Due to Resignation for Good Reason ($) | Due to Resignation for Any Reason ($) | ||||||||||||||
Mr. Grady | Cash Severance Payment – 100% Annual Base Salary(1) | — | — | 1,380,000 | 1,380,000 | — | ||||||||||||||
Cash Severance Payment – Cash Incentive Plan Compensation(2) | — | — | 2,318,400 | 2,318,400 | — | |||||||||||||||
Continued Coverage of Medical Benefits(3) | — | — | 194,176 | 194,176 | — | |||||||||||||||
Total Value of Termination Benefits | — | — | 3,892,576 | 3,892,576 | — | |||||||||||||||
Dr. Gill | Cash Severance Payment – Monthly Base Salary x 21 Years of Employment(1) | 1,968,750 | 1,968,750 | 1,968,750 | 1,968,750 | 1,968,750 | ||||||||||||||
Cash Severance Payment – Cash Incentive Plan Compensation(2) | 1,755,000 | 1,755,000 | 1,755,000 | 1,755,000 | 1,755,000 | |||||||||||||||
Continued Coverage of Medical Benefits(3) | 65,206 | 65,206 | 65,206 | 65,206 | 65,206 | |||||||||||||||
Equity Award Acceleration(4) | 7,338,139 | 7,338,139 | 7,338,139 | 7,338,139 | 7,338,139 | |||||||||||||||
Total Value of Termination Benefits(5) | 11,127,095 | 11,127,095 | 11,127,095 | 11,127,095 | 11,127,095 | |||||||||||||||
Mr. Sverha | Cash Severance Payment – 50% Annual Base Salary(1) | — | — | 375,314 | 375,314 | — | ||||||||||||||
Cash Severance Payment – Cash Incentive Plan Compensation(2) | — | — | 900,754 | 900,754 | — | |||||||||||||||
Continued Coverage of Medical Benefits(6) | — | — | 96,300 | 96,300 | — | |||||||||||||||
Total Value of Termination Benefits | — | — | 1,372,368 | 1,372,368 | — | |||||||||||||||
Mr. Archer | Cash Severance Payment – 50% Annual Base Salary(1) | — | — | 270,000 | 270,000 | — | ||||||||||||||
Cash Severance Payment – Cash Incentive Plan Compensation(2) | — | — | 550,800 | 550,800 | — | |||||||||||||||
Continued Coverage of Medical Benefits(6) | — | — | 72,352 | 72,352 | — | |||||||||||||||
Total Value of Termination Benefits | — | — | 893,152 | 893,152 | — | |||||||||||||||
(1) | Assumes an annual base salary of $1,380,000 for Mr. Grady, $1,125,000 for Dr. Gill, $750,628 for Mr. Sverha, and $540,000 for Mr. Archer (salaries in effect on June 26, 2026). Mr. Sverha’s salary is paid in Thai baht and was converted to U.S. dollars using the Fabrinet Corporate Group THB to USD Exchange Rate, which was the Bank of Thailand’s middle rate (midpoint of the bid and ask rates) as of June 26, 2025, of 32.48 Thai baht to 1 U.S. dollar. |
(2) | Reflects the amount of bonus earned under the Fiscal 2026 Bonus Plan but unpaid as of June 26, 2026. Mr. Sverha’s bonus compensation is paid in Thai baht and was converted to U.S. dollars using the Fabrinet Corporate Group THB to USD Exchange Rate, which was the Bank of Thailand’s middle rate (midpoint of the bid and ask rates) as of June 26, 2025, of 32.48 Thai baht to 1 U.S. dollar. |
(3) | Reflects two times the annual cost of COBRA coverage to maintain the benefits provided as of June 26, 2026. |
(4) | Potential value if vesting of eligible RSUs held by Dr. Gill had been accelerated on June 26, 2026, assuming a share price of $524.79, the closing price on the NYSE of our ordinary shares on June 26, 2026. |
(5) | Does not include the future tax equalization benefits that such Named Officer may be entitled to under our expatriate policy, as described above in “Executive Compensation—Compensation Discussion and Analysis.” As of June 26, 2026, Dr. Gill was our only Named Officer that was entitled to these benefits. The amount of any future tax equalization benefit can vary significantly depending, among other factors, on the individual’s personal tax circumstances with respect to the year for which the benefit is provided. The amount of tax equalization benefit paid in fiscal 2026 was $722,979 for Dr. Gill. Tax equalization benefits for any future years may differ substantially from such amount. |
(6) | Reflects 18 times the monthly premium for continued health coverage under COBRA to maintain the benefits provided as of June 26, 2026. |
60 | ![]() | 2026 PROXY STATEMENT | ||||
TABLE OF CONTENTS
Name | Type of Benefit | Due to Death ($) | Due to Disability ($) | Without Cause ($) | Due to Resignation for Good Reason ($) | Due to Resignation for Any Reason ($) | ||||||||||||||
Mr. Grady | Cash Severance Payment – 200% Annual Base Salary(1) | — | — | 2,760,000 | 2,760,000 | — | ||||||||||||||
Cash Severance Payment – Cash Incentive Plan Compensation(2) | — | — | 2,318,400 | 2,318,400 | — | |||||||||||||||
Cash Severance Payment – 200% Cash Incentive Target Bonus Opportunity(3) | — | — | 3,864,000 | 3,864,000 | — | |||||||||||||||
Continued Coverage of Medical Benefits(4) | — | — | 194,176 | 194,176 | — | |||||||||||||||
Equity Award Vesting Acceleration(5) | — | — | 34,928,448 | 34,928,448 | — | |||||||||||||||
Total Value of Termination Benefits | — | — | 44,065,024 | 44,065,024 | — | |||||||||||||||
Dr. Gill | Cash Severance Payment – Monthly Base Salary x 21 Years of Employment(1) | 1,968,750 | 1,968,750 | 1,968,750 | 1,968,750 | 1,968,750 | ||||||||||||||
Cash Severance Payment – Cash Incentive Plan Compensation(2) | 1,755,000 | 1,755,000 | 1,755,000 | 1,755,000 | 1,755,000 | |||||||||||||||
Continued Coverage of Medical Benefits(4) | 65,206 | 65,206 | 65,206 | 65,206 | 65,206 | |||||||||||||||
Equity Award Vesting Acceleration(5) | 20,707,689 | 20,707,689 | 20,707,689 | 20,707,689 | 20,707,689 | |||||||||||||||
Total Value of Termination Benefits(6) | 24,496,645 | 24,496,645 | 24,496,645 | 24,496,645 | 24,496,645 | |||||||||||||||
Mr. Sverha | Cash Severance Payment – 100% Annual Base Salary(1) | — | — | 750,628 | 750,628 | — | ||||||||||||||
Cash Severance Payment – Cash Incentive Plan Compensation(2) | — | — | 900,754 | 900,754 | — | |||||||||||||||
Cash Severance Payment – 100% Cash Incentive Target Bonus Opportunity(3) | — | — | 750,628 | 750,628 | — | |||||||||||||||
Continued Coverage of Medical Benefits(7) | — | — | 96,300 | 96,300 | — | |||||||||||||||
Equity Award Vesting Acceleration(5) | — | — | 12,204,516 | 12,204,516 | — | |||||||||||||||
Total Value of Termination Benefits | — | — | 14,702,826 | 14,702,826 | — | |||||||||||||||
Mr. Archer | Cash Severance Payment – 100% Annual Base Salary(1) | — | — | 540,000 | 540,000 | — | ||||||||||||||
Cash Severance Payment – Cash Incentive Plan Compensation(2) | — | — | 550,800 | 550,800 | — | |||||||||||||||
Cash Severance Payment – 100% Cash Incentive Target Bonus Opportunity(3) | — | — | 459,000 | 459,000 | — | |||||||||||||||
Continued Coverage of Medical Benefits(7) | — | — | 72,352 | 72,352 | — | |||||||||||||||
Equity Award Vesting Acceleration(5) | — | — | 9,843,486 | 9,843,486 | — | |||||||||||||||
Total Value of Termination Benefits | — | — | 11,465,638 | 11,465,638 | — | |||||||||||||||
(1) | Assumes an annual base salary of $1,380,000 for Mr. Grady, $1,125,000 for Dr. Gill, $750,628 for Mr. Sverha, and $540,000 for Mr. Archer (salaries in effect on June 26, 2026). Mr. Sverha’s salary is paid in Thai baht and was converted to U.S. dollars using the Fabrinet Corporate Group THB to USD Exchange Rate, which was the Bank of Thailand’s middle rate (midpoint of the bid and ask rates) as of June 26, 2025, of 32.48 Thai baht to 1 U.S. dollar. |
(2) | Reflects the amount of bonus earned under the Fiscal 2026 Bonus Plan but unpaid as of June 26, 2026. Mr. Sverha’s bonus compensation is paid in Thai baht and was converted to U.S. dollars using the Fabrinet Corporate Group THB to USD Exchange Rate, which was the Bank of Thailand’s middle rate (midpoint of the bid and ask rates) as of June 26, 2025, of 32.48 Thai baht to 1 U.S. dollar. |
(3) | Assumes an annual target bonus opportunity of $1,932,000 for Mr. Grady, $750,628 for Mr. Sverha, and $459,000 for Mr. Archer (target bonus opportunities in effect on June 26, 2026). |
(4) | Reflects two times the annual cost of COBRA coverage to maintain the benefits provided as of June 26, 2026. |
(5) | Potential value if vesting of eligible RSUs held by the Named Officer had been accelerated June 26, 2026, assuming a share price of $524.79, the closing price on the NYSE of our ordinary shares on June 26, 2026. Also assumes that, in the case of performance-based equity awards outstanding as of June 26, 2026, the performance conditions were deemed achieved in full and such awards were converted into RSUs as described in “—Treatment of Performance-Based Awards in Change in Control” above. |
(6) | Does not include the future tax equalization benefits that such Named Officer may be entitled to under our expatriate policy, as described above in “Executive Compensation—Compensation Discussion and Analysis.” As of June 26, 2026, Dr. Gill was our only Named Officer that was entitled to these benefits. The amount of any future tax equalization benefit can vary significantly depending, among other factors, on the individual’s personal tax circumstances with respect to the year for which the benefit is provided. The amount of tax equalization benefit paid in fiscal 2026 was $722,979 for Dr. Gill. Tax equalization benefits for any future years may differ substantially from such amount. |
(7) | Reflects 18 times the monthly premium for continued health coverage under COBRA to maintain the benefits provided as of June 26, 2026. |
![]() | 2026 PROXY STATEMENT | 61 | ||
TABLE OF CONTENTS
62 | ![]() | 2026 PROXY STATEMENT | ||||
TABLE OF CONTENTS
Fiscal Year(1) | Summary Compensation Table Total for PEO ($)(2) | Compensation Actually Paid to PEO ($)(3) | Average Summary Compensation Table Total for Non-PEO NEOs ($)(4) | Average Compensation Actually Paid to Non-PEO NEOs ($)(5) | Value of Initial Fixed $100 Investment Based On: | Net Income ($)(8) | Company Selected Measure (Revenue) ($)(9) | |||||||||||||||||||
Total Shareholder Return($)(6) | Peer Group Total Shareholder Return($)(7) | |||||||||||||||||||||||||
2026 | | |||||||||||||||||||||||||
2025 | ||||||||||||||||||||||||||
2024 | ||||||||||||||||||||||||||
2023 | ||||||||||||||||||||||||||
2022 | ||||||||||||||||||||||||||
(1) | The following table shows our PEO and non-PEO NEOs for each of the reported fiscal years. |
Fiscal 2026 | Fiscal 2025 | Fiscal 2024 | Fiscal 2023 | Fiscal 2022 | |||||||||||||
PEO | |||||||||||||||||
Non-PEO NEOs | Dr. Harpal Gill | Dr. Harpal Gill | Dr. Harpal Gill | Dr. Harpal Gill | Dr. Harpal Gill | ||||||||||||
Csaba Sverha | Csaba Sverha | Csaba Sverha | Csaba Sverha | Csaba Sverha | |||||||||||||
Edward T. Archer | Edward T. Archer | Edward T. Archer | Edward T. Archer | Edward T. Archer | |||||||||||||
(2) | The dollar amounts reported in this column are the amounts of total compensation reported for our PEO in the “Total” column of the Summary Compensation Table for the applicable fiscal year. |
(3) | CAP does not mean that our PEO was actually paid the amounts reported in this column, but is a dollar amount derived from the starting point of total compensation reported for our PEO in the “Total” column of the Summary Compensation Table for the applicable fiscal year, as adjusted in accordance with SEC rules. For purposes of calculating CAP, the fair value of equity awards is calculated in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718 (FASB ASC Topic 718) using the same assumption methodologies used to calculate the grant date fair value of awards for purposes of the Summary Compensation Table. In accordance with SEC rules, the following adjustments were made to determine CAP to our PEO for fiscal 2026, which consisted solely of adjustments to equity awards: |
Adjustment Table for PEO | Fiscal 2026 | ||||
Summary Compensation Table Total for PEO | $ | ||||
Subtract grant date fair value of equity awards reported in Summary Compensation Table | ( | ||||
Add the fair value as of the end of the covered fiscal year of equity awards granted in the covered fiscal year that are outstanding and unvested as of the end of the covered fiscal year | |||||
Adjust for the change in fair value as of the end of covered fiscal year (from the end of the prior fiscal year) of equity awards granted in prior fiscal years that are outstanding and unvested as of the end of covered fiscal year | |||||
Add, for equity awards that are granted and vest in the same covered fiscal year, the fair value as of the vesting date | |||||
Adjust for the change in fair value as of vesting date (from the end of the prior fiscal year) of equity awards granted in prior fiscal years for which all applicable vesting conditions were satisfied at the end of or during the covered fiscal year | |||||
Subtract, for equity awards granted in any prior fiscal year that fail to meet the applicable vesting conditions during the covered fiscal year, the fair value as of the end of prior fiscal year | |||||
Total Equity Adjustments (subtotal) | |||||
Compensation Actually Paid to PEO | $ | ||||
(4) | The dollar amounts reported in this column are the average of the amounts of total compensation reported for our non-PEO NEOs in the “Total” column of the Summary Compensation Table for the applicable fiscal year. |
![]() | 2026 PROXY STATEMENT | 63 | ||
TABLE OF CONTENTS
(5) | CAP does not mean that our non-PEO NEOs were actually paid the amounts reported in this column, but is a dollar amount derived from the starting point of the average total compensation reported for our non-PEO NEOs in the “Total” column of the Summary Compensation Table for the applicable fiscal year, as adjusted in accordance with SEC rules. For purposes of calculating CAP, the fair value of equity awards is calculated in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718 (FASB ASC Topic 718) using the same assumption methodologies used to calculate the grant date fair value of awards for purposes of the Summary Compensation Table. In accordance with SEC rules, the following adjustments were made to determine the average CAP to our non-PEO NEOs during fiscal 2026, which consisted solely of adjustments to equity awards: |
Adjustment Table for non-PEO NEOs | Fiscal 2026 | ||||
Average Summary Compensation Table Total for non-PEO NEOS | $ | ||||
Subtract grant date fair value of equity awards reported in Summary Compensation Table | ( | ||||
Add the fair value as of the end of the covered fiscal year of equity awards granted in the covered fiscal year that are outstanding and unvested as of the end of the covered fiscal year | |||||
Adjust for the change in fair value as of the end of covered fiscal year (from the end of the prior fiscal year) of equity awards granted in prior fiscal years that are outstanding and unvested as of the end of covered fiscal year | |||||
Add, for equity awards that are granted and vest in the same covered fiscal year, the fair value as of the vesting date | |||||
Adjust for the change in fair value as of vesting date (from the end of the prior fiscal year) of equity awards granted in prior fiscal years for which all applicable vesting conditions were satisfied at the end of or during the covered fiscal year | |||||
Subtract, for equity awards granted in any prior fiscal year that fail to meet the applicable vesting conditions during the covered fiscal year, the fair value as of the end of prior fiscal year | |||||
Total Equity Adjustments (subtotal) | |||||
Average Compensation Actually Paid to non-PEO NEOs | $ | ||||
(6) | Total shareholder return is calculated by assuming that a $100 investment was made on the day prior to the first fiscal year reported and reinvesting all dividends until the last day of each reported fiscal year. |
(7) | The peer group used is the NASDAQ Telecommunications Index, which we also use in the stock performance graph required by Item 201(e) of Regulation S-K under the Securities Exchange Act of 1934, as amended, and included in our Annual Report on Form 10-K for the fiscal year ended June 26, 2026. Peer group total shareholder return is calculated by assuming that a $100 investment was made on the day prior to the first fiscal year reported and reinvesting all dividends until the last day of each reported fiscal year. |
(8) | The dollar amounts reported in this column are the amounts of net income reflected in our audited financial statements for the reported fiscal year. |
(9) | In our assessment, |
• |
• |
• |
• |
64 | ![]() | 2026 PROXY STATEMENT | ||||
TABLE OF CONTENTS


![]() | 2026 PROXY STATEMENT | 65 | ||
TABLE OF CONTENTS
66 | ![]() | 2026 PROXY STATEMENT | ||||
TABLE OF CONTENTS
• | any of our directors or executive officers; |
• | any nominee for election as one of our directors; |
• | any person or entity that beneficially owns more than five percent of our outstanding shares; or |
• | any member of the immediate family of any of the foregoing persons. |
![]() | 2026 PROXY STATEMENT | 67 | ||
TABLE OF CONTENTS
• | each person (or group of affiliated persons) who is known by us to beneficially own more than 5% of our ordinary shares; |
• | each of our Named Officers; |
• | each of our directors and director nominees; and |
• | all of our directors and current executive officers as a group. |
Name of Beneficial Owner | Shares Beneficially Owned (#) | Percentage Beneficially Owned (%) | ||||||
5% Shareholders: | ||||||||
BlackRock, Inc.(1) | 3,852,554 | 10.75 | ||||||
Vanguard Portfolio Management(2) | 2,166,241 | 6.05 | ||||||
T. Rowe Price Associates, Inc.(3) | 1,941,001 | 5.42 | ||||||
Vanguard Capital Management(4) | 1,881,214 | 5.25 | ||||||
FMR LLC(5) | 1,841,854 | 5.14 | ||||||
Named Officers: | ||||||||
Seamus Grady | 15,033 | * | ||||||
Dr. Harpal Gill | 9,439 | * | ||||||
Csaba Sverha | 10,297 | * | ||||||
Edward T. Archer | 1,942 | * | ||||||
Non-Employee Directors: | ||||||||
Forbes I.J. Alexander | 1,356 | * | ||||||
Dr. Homa Bahrami | 15,816 | * | ||||||
Caroline Dowling | 93 | * | ||||||
Thomas F. Kelly | 16,764 | * | ||||||
Dr. Frank H. Levinson | 6,604 | * | ||||||
All directors and current executive officers as a group (9 persons) | 77,344 | * | ||||||
* | Represents less than 1% of the total. |
(1) | Based on a Schedule 13G/A filed with the SEC on July 28, 2026, BlackRock, Inc. (“BlackRock”) has sole voting power as to 3,673,246 shares and sole dispositive power as to 3,852,554 shares. BlackRock’s address is 50 Hudson Yards, New York, NY 10001. |
(2) | Based on a Schedule 13G filed with the SEC on April 28, 2026, Vanguard Portfolio Management (“VPM”) has sole voting power as to 32,087 shares and sole dispositive power as to 2,166,241 shares. VPM’s address is 100 Vanguard Blvd., Malvern, PA 19355. |
(3) | Based on a Schedule 13G/A filed with the SEC on July 8, 2026, T. Rowe Price Associates, Inc. (“T. Rowe Price”) has sole voting power as to 1,870,142 shares and sole dispositive power as to 1,941,001 shares. T. Rowe Price’s address is 1307 Point Street, Baltimore, MD 21231. |
(4) | Based on a Schedule 13G filed with the SEC on April 28, 2026, Vanguard Capital Management (“VCM”) has sole voting power as to 274,233 shares and sole dispositive power as to 1,881,214 shares. VCM’s address is 100 Vanguard Blvd., Malvern, PA 19355. |
(5) | Based on a Schedule 13G/A filed with the SEC on August 6, 2026, FMR LLC (“FMR”) has sole voting power as to 1,718,079 shares and sole dispositive power as to 1,841,854 shares. FMR’s address is 245 Summer Street, Boston, MA 02210. |
68 | ![]() | 2026 PROXY STATEMENT | ||||
TABLE OF CONTENTS
Plan Category | (a) Number of Securities to be Issued Upon Exercise of Outstanding Options, Warrants and Rights (#) | (b) Weighted- Average Exercise Price of Outstanding Options, Warrants and Rights ($) | (c) Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (Excluding Securities Reflected in Column (a)) (#) | ||||||||
Equity compensation plans approved by security holders | 306,261(1) | — | 1,455,660 | ||||||||
Equity compensation plans not approved by security holders(2) | — | — | 111,347 | ||||||||
Total | 306,261 | — | 1,567,007 | ||||||||
(1) | Consists of shares issuable upon outstanding awards under the 2020 Equity Incentive Plan. This amount represents an aggregate of 211,574 shares subject to RSUs and 94,687 shares subject to PSUs that were outstanding as of June 26, 2026. |
(2) | We adopted the 2017 Inducement Equity Incentive Plan on November 2, 2017, with a reserve of 160,000 ordinary shares authorized for future issuance solely for the granting of inducement share options and equity awards to new employees. The plan was adopted without shareholder approval in reliance on the “employment inducement exemption” provided under the NYSE Listed Company Manual. |
![]() | 2026 PROXY STATEMENT | 69 | ||
TABLE OF CONTENTS
(in thousands of U.S. dollars) | Twelve Months Ended | |||||||
June 26, 2026 | June 27, 2025 | |||||||
Revenue | $4,641,097 | $3,419,327 | ||||||
Gross profit (GAAP) | $556,511 | $413,349 | ||||||
Share-based compensation expenses | 11,459 | 10,456 | ||||||
Gross profit (non-GAAP) | $567,970 | $423,805 | ||||||
Gross margin (GAAP) | 12.0% | 12.1% | ||||||
Gross margin (non-GAAP) | 12.2% | 12.4% | ||||||
![]() | 2026 PROXY STATEMENT | A-1 | ||
TABLE OF CONTENTS
(in thousands of U.S. dollars) | Twelve Months Ended | |||||||
June 26, 2026 | June 27, 2025 | |||||||
Revenue | $4,641,097 | $3,419,327 | ||||||
Operating profit (GAAP) | $462,887 | $324,447 | ||||||
Share-based compensation expenses | 34,630 | 33,004 | ||||||
Severance payment and others | 1,109 | 748 | ||||||
Legal and litigation costs | 1,320 | 1,077 | ||||||
Restructuring and other related costs | 117 | 1,436 | ||||||
Operating profit (non-GAAP) | $500,063 | $360,712 | ||||||
Operating margin (GAAP) | 10.0% | 9.5% | ||||||
Operating margin (non-GAAP) | 10.8% | 10.5% | ||||||
(in thousands of U.S. dollars, except share and per share data) | Twelve Months Ended | |||||||||||||
June 26, 2026 | June 27, 2025 | |||||||||||||
Net Income | Diluted EPS | Net Income | Diluted EPS | |||||||||||
Net income (GAAP measure) | $473,027 | $13.05 | $332,527 | $9.17 | ||||||||||
Items reconciling GAAP net income & EPS to non-GAAP net income & EPS: | ||||||||||||||
Related to cost of revenues: | ||||||||||||||
Share-based compensation expenses | 11,459 | 0.32 | 10,456 | 0.29 | ||||||||||
Total related to cost of revenues | 11,459 | 0.32 | 10,456 | 0.29 | ||||||||||
Related to selling, general and administrative expenses: | ||||||||||||||
Share-based compensation expenses | 23,171 | 0.64 | 22,548 | 0.62 | ||||||||||
Legal and litigation costs | 1,320 | 0.03 | 1,077 | 0.03 | ||||||||||
Severance payment and others | 1,109 | 0.03 | 748 | 0.02 | ||||||||||
Total related to selling, general and administrative expenses | 25,600 | 0.70 | 24,373 | 0.67 | ||||||||||
Related to restructuring and other related costs: | ||||||||||||||
Restructuring and other related costs | 117 | 0.00 | 1,436 | 0.04 | ||||||||||
Total related to restructuring and other related costs | 117 | 0.00 | 1,436 | 0.04 | ||||||||||
Related to other income and other expense: | ||||||||||||||
Non-marketable equity securities revaluation | (56,743) | (1.56) | — | — | ||||||||||
Total related to other income and other expense | (56,743) | (1.56) | — | — | ||||||||||
Related to income tax (benefit) expense: | ||||||||||||||
Tax provision related to Pillar Two | 57,447 | 1.58 | — | — | ||||||||||
Total related to income tax (benefit) expense | 57,447 | 1.58 | — | — | ||||||||||
Total related to net income & EPS | 37,880 | 1.04 | 36,265 | 1.00 | ||||||||||
Non-GAAP net income | $510,907 | $14.09 | $368,792 | $10.17 | ||||||||||
Shares used in computing diluted net income per share (in thousands) | ||||||||||||||
GAAP diluted shares | 36,252 | 36,267 | ||||||||||||
Non-GAAP diluted shares | 36,252 | 36,267 | ||||||||||||
A-2 | ![]() | 2026 PROXY STATEMENT | ||||
TABLE OF CONTENTS

TABLE OF CONTENTS








